curriculum vitae leonid poretsky, m.d. · 2019-11-14 · curriculum vitae leonid poretsky, m.d....
TRANSCRIPT
CURRICULUM VITAE LEONIDPORETSKY,M.D.
11/13/2019 ADDRESS: Home: 1025FifthAvenue,#8ES NewYork,N.Y.10028
Business:NorthwellHealth–LenoxHillHospital100East77thStreetNewYork,N.Y.10075
TELEPHONE: (212)434-4972(office)DATEOFBIRTH: August7,1954PLACEOFBIRTH: Leningrad,Russia(USSR)CITIZENSHIP: UnitedStates,1985
ImmigratedtoU.S.A.in1979MEDICALSCHOOL:1971-1977 M.D.,CumLaude
FirstMedicalInstituteLeningrad,Russia(USSR)
CURRENTPOSITIONS: 2014–Present Chief,DivisionofEndocrinology AssociateChairman,DepartmentofMedicine NorthwellHealth–LenoxHillHospital NewYork,NewYork10075
ProfessorofMedicine DonaldandBarbaraZuckerSchoolofMedicineatHofstraNorthwell
PREVIOUSHOSPITALAPPOINTMENTS:2000–2014 InterimChairman,DepartmentofMedicine(2014) Chief,DivisionofEndocrinology&Metabolism(2000)
GeraldJ.FriedmanChairinEndocrinology(2004) ProgramDirector,FellowshipinEndocrinologyandMetabolism(2000) Director,GeraldJ.FriedmanDiabetesInstitute(2007) ResearchIntegrityOfficer(2012) MountSinaiBethIsrael NewYork,NewYork
2012–2014 Vice-ChairmanforResearch,DepartmentofMedicine MountSinaiBethIsrael NewYork,NewYork
LEONIDPORETSKY,M.D.
2
1995-2000 Director,DiabetesCenterAssociateDirector,GeneralClinicalResearchCenterProfessorofMedicineandGynecology(1999)NewYorkHospital/CornellMedicalCenterNewYork,NewYork
1989-1995 Chief,DivisionofEndocrinologyandMetabolism,
CabriniMedicalCenterNewYork,NewYork
1985-1989 Head,DiabetesSection
DivisionofEndocrinologyandMetabolismDepartmentofMedicineBethIsraelMedicalCenterNewYork,NewYork
1983-1985 FellowinEndocrinology,
BethIsraelHospitalBoston,Massachusetts
1983-1985 Physician(part-time),JoslinDiabetesCenter,Boston,Massachusetts
1982–1983 ChiefResidentinMedicine, ConeyIslandHospital, Brooklyn,NewYork1980–1982 ResidentinMedicine, ConeyIslandHospital, Brooklyn,NewYork1978-1979 Physician,MedicalEmergencyStation
Leningrad,Russia(USSR)1977-1978 Physician,
DepartmentofInternalMedicineStateHospitalNumber21Leningrad,Russia(USSR)
PREVIOUSMEDICALSCHOOLAPPOINTMENTS:2000-2014 ProfessorofMedicine,AlbertEinsteinCollegeofMedicine(2000)
ProfessorofMedicine,IcahnSchoolofMedicineatMountSinai(2014)1999-2000 ProfessorofMedicineandGynecology WeillMedicalCollegeofCornellUniversity NewYork,NewYork
LEONIDPORETSKY,M.D.
3
1995-1999 AssociateProfessorofMedicineandGynecologyCornellUniversityMedicalCollegeNewYork,NewYork
1990-1995 AssociateProfessorofMedicine
NewYorkMedicalCollegeValhalla,NewYork
1989-1990 AssociateProfessorofMedicine
Mt.SinaiSchoolofMedicineCityUniversityofNewYorkNewYork,NewYork
1985-1989 AssistantProfessorofMedicine
Mt.SinaiSchoolofMedicineCityUniversityofNewYorkNewYork,NewYork
POSTDOCTORALTRAINING:2003 MedicalInformaticsMBL/NLMCourseFellow
MarineBiologicalLaboratorySponsoredbytheNationalLibraryofMedicineWoodsHole,Massachusetts
1983-1985 ResearchFellowinMedicine,
HarvardMedicalSchool,CharlesA.DanaResearchInstituteandTheHarvard-ThorndikeLaboratory.FellowinEndocrinologyandDiabetes,Boston’sBeth IsraelHospital,with clinical duties atBrighamMedicalGroupandHarvardCommunityHealthPlan,Boston,Massachusetts
1982-1983 ChiefResident,
DepartmentofMedicine,ConeyIslandHospital,Brooklyn,NewYork
1980-1982 ResidentinMedicine,
ConeyIslandHospital,Brooklyn,NewYork
LICENSUREANDCERTIFICATION:1985 Diplomate
AmericanBoardofEndocrinologyandMetabolismCert.#90042
LEONIDPORETSKY,M.D.
4
1983 Diplomate,AmericanBoardofInternalMedicineCert.#900421996 PennsylvaniaStateLicenseRegistration#MD-057239-L1983 NewYorkStateLicenseRegistration#155121-11983 MassachusettsLicenseRegistration#510421982 CaliforniaLicenseRegistration#A392571981 MarylandLicenseRegistration#D269361981 FLEXExaminationpassedJune,19811980 ECFMGCertificate#314376-6TEACHINGEXPERIENCE:2014-Present Chief,DivisionofEndocrinology,DiabetesandMetabolism AssociateChairmanforResearch,DepartmentofMedicine
LenoxHillHospital Professor of Medicine, Donald and Barbara Zucker School of Medicine at HofstraNorthwellandFeinsteinInstituteforMedicalResearchTeaching rotatinghighschool, collegeandmedical students;mentoring residents inmedicine and fellows in endocrinology. Co-Director,weekly divisional conferencesand annual Feinstein Institute research symposia “Diabetes, endocrinology andmetabolicdisorders.”
2000-2014 Chief,DivisionofEndocrinologyandMetabolism,
BethIsraelMedicalCenter.Teachingmedicalstudents,residentsandfellows.
ProgramDirectorforthefellowshiptrainingprogram. 1995-2000 Director,DiabetesCenter,NewYorkHospital-
CornellMedicalCenter,NewYork,NYFacultyMember for the following problem based learning (PBL) courses: “HumanStructureandFunction”and“FromMoleculestoCells”.Preceptorforthetriplejumpexamination(2ndyearmedicalstudents).Writingquestionsforthepathophysiologyexamination (2nd year medical students). Lectures for medical students: “Type 1diabetes mellitus” and “Insulin and glucagon.” Endocrine grand rounds: “Role ofinsulin and insulin-like growth factors in ovarian function” and “Polycystic ovarysyndrome.” Medical grand rounds: “Syndromes of insulin resistance.” Teachingresidents and fellows in clinical setting (attending ward physician in internalmedicineandendocrinology;attendingphysicianintheendocrineclinicandhigh-riskpregnancy clinic). Member, Cornell University Medical College Department ofMedicine Postgraduate Education Advisory Committee and Update in MedicineCommittee.LecturesthroughoutNewYorkMetropolitanareaonthetopicofinsulin
LEONIDPORETSKY,M.D.
5
resistance (Columbia University, New York University School of Medicine, MountSinaiSchoolofMedicine,AlbertEinsteinCollegeofMedicine).
1989-1995 Chief,DivisionofEndocrinologyandMetabolism
CabriniMedicalCenter,NewYork,NYRoundswithhousestaffandmedicalstudents inendocrinology& internalmedicine.Organizing endocrine conferences and board review courses for residents.Organizing inter-institutional endocrine grand rounds, (Cabrini Medical Center, St.VincentMedical Center,Rogosin Institute). Lecturingon insulin receptordisordersandendocrinologicalaspectsofAIDS.
1985-1989 Head,DiabetesSectionBethIsraelMedicalCenter,NewYork,NY
Conducting rounds with housestaff and medical students; responsible for weeklyendocrine grand rounds and monthly research conferences. Lecturing on insulinreceptordisorders.
1983-1985 FellowinEndocrinologyandMetabolism,Boston’sBethIsraelHospitalandHarvard
MedicalSchoolWhile on clinical service, supervised students and residents rotating through theservice; presented endocrine grand rounds on the following subjects: Lipoatrophicdiabetes;Insulinreceptorsinhealthanddisease;andInsulineffectsintheovary.
1982-1983 ChiefResident,DepartmentofMedicine,Coney IslandHospital,Brooklyn,NewYork
Teaching residents in a clinical setting; conducting daily MICU rounds and weeklyclinicalconferences.
1982-1983 Preceptor for Physical Diagnosis Course, Sophie Davis School of Biomedical
Education,CityUniversityofNewYork.1971-1977 Teachingbiologycourseforpremedicalstudents,
FirstMedicalInstitute,Leningrad,Russia(USSR).COMMITTEEMEMBERSHIPS:CommitteeonScholarlyActivities,MountSinaiBethIsrael,NewYork,NewYorkDepartmentofMedicineDivisionChiefs,MountSinaiBethIsrael,NewYork,NewYorkDiabetesCareEnhancementInitiativeCommittee,BethIsraelMedicalCenter,NewYork,NewYorkMAJORRESEARCHINTERESTS:Mechanismsof insulinandinsulin-likegrowthfactoractionintheovary;endocrinologicalaspectsofAIDS;clinicaloutcomesindiabetes.GrantSupport:2019-Ongoing Mentor(LenoxHillHospital)–“TransgenderHealthAgingStudyandRegistry”–NY
StateDepartmentofHealth,EmpireClinicalResearchProgram(ECRIP).Directcosts$574,166.00.
LEONIDPORETSKY,M.D.
6
2017-Ongoing ProjectDirector(LenoxHillHospital)–“Obesityasamultifactorialdisease:Energy metabolism,insulinresistance, microbiomeandendoscopicbariatricintervention in human obesity” – NY State Department of Health, Empire Clinical Research
Program(ECRIP).Directcosts$698,8882017-Ongoing Site Principal Investigator – Role of CAP1 in mediating resistin action in obesity-
inducedinsulinresistance.GeraldJ.andDorothyR.FriedmanNewYorkFoundationforMedicalResearch
2017–Ongoing SiteCo-Investigator–Novartis (Site-Principal Investigator–Dr. JohnBoockvar): A
Phase III,multi-center, randomized, double blind, 48week studywith an initial 12weekplacebo-controlledperiodtoevaluatethesafetyandefficacyofosilodrostat inpatientswithCushing’sdisease.
2015–Ongoing SitePrincipalInvestigator–“Theeffectofstructuredoutpatientdiabetesprogramonhospitalreadmissionratesinpatientswithdiabetes”-NYStateDepartmentofHealth,EmpireClinicalResearchInvestigationProgram(ECRIP).Initiallyfunded2015-2017,directcosts$150,000.00
2017-2019 Site Principal Investigator – Sanofi: Sotagliflozin compared to empagliflozin and
placebo in patientswith type 2 diabeteswho have inadequate glycemic control onDipeptidyl Peptidase 4 Inhibitor (DPP4I)with orwithoutmetformin -amulticenterclinicaltrial.
2017-2019 SitePrincipal Investigator–Sanofi: TheSCOREDTrial, a randomized,doubleblind,
placebo-controlled, parallel-group, multicenter study to demonstrate the effects ofsotagliflozin on cardiovascular and renal events in patients with type 2 diabetes,cardiovascular risk factors and moderately impaired renal function, a multi-centerclinicaltrial.
2016–2019 SiteCo-Investigator(LenoxHillHospital);NIDDKGrantNumberUO1DK098245-03.
VitaminD and type 2 diabetes (D2d study). Principal Investigator: Anastassios G.Pittas,MD,TuftsUniversity.IRBNo.HS16-0144.
2016–2017 SitePrincipalInvestigator-Sanofi:APhaseIVrandomized,open-label,parallelgroup
realworldpragmatictrialtoassesstheclinicalandhealthoutcomesofToujeocomparedtocommerciallyavailablebasalinsulinsforinitiationoftherapyininsulinnaïvepatientswithuncontrolledtype2diabetesmellitus.
2016–2017 SitePrincipalInvestigator-Novartis:Amulti-center,randomized,open-label,Phase
IVstudytoinvestigatethemanagementofpasireotide-inducedhyperglycemiawithincretinbasedtherapyorinsulininadultpatientswithCushing’sdiseaseoracromegaly.
2014 Satellite Principal Investigator (Beth Israel); NIDDK Grant Number NCT02017171.Preventing Early Renal Loss in Diabetes (PERL): A multicenter clinical trial ofallopurinoltopreventGFRlossintype1diabetes.PrincipalInvestigator:AlessandroDoria,MDPhDMPH,JoslinDiabetesCenter.DirectCost:$315,850.00.
LEONIDPORETSKY,M.D.
7
2013–2014 Site Principal Investigator (Beth Israel); NIDDK Grant Number U01DK098245(implementation phase). Vitamin D and type 2 diabetes (D2d study). PrincipalInvestigator:AnastassiosG.Pittas,MD,TuftsUniversity.DirectCost:$153,583.00.
2012–2013 SitePrincipal Investigator (Beth Israel); Genzyme Inc.,MountSinaiMedicalCenter.
Multi-center study of the effect of Sevelamer carbonate onmetabolic/inflammatory/reactive oxygen speciesmarkers in diabetes patientswithnephropathy. Principal Investigator: GaryStriker,MD,MountSinaiMedicalCenter.DirectCost:$119,844.00.
2011–2013 Co-Investigator, NIH National Center for Minority Health and Health Disparities,
Bronx Center to Reduce and Eliminate Ethnic and Racial Health Disparities, AlbertEinsteinCollegeofMedicine. Activatingpeople fordiseaseprevention and lifestylechangethroughempowerment(APPLE).PrincipalInvestigator:AlisonKarasz,Ph.D.,AlbertEinsteinCollegeofMedicine.
2011-2012 Co-investigator;NIDDKGrantNumberU34DK091958(planningphase).VitaminDfor
preventionoftype2Diabetes(D2Dstudy).PrincipalInvestigator:AnastassiosPittas,MD,TuftsUniversity.DirectCost:$161,463.00.
2009–2014 Advisor; NIH #K07AT004570-01A2. Academic career development award in
Complementary and Alternative Medicine Research and Education. PrincipalInvestigator:BenjaminKligler,MD,MPH,BethIsraelMedicalCenter.
2009–2011 Co-investigator; Chinese American Medical Society and Chinese American
IndependentPracticeAssociationResearchFund.Geneticmarkersforincreasedriskof gestational diabetes in Chinese-Americans. Principal Investigator: Donna Seto-Young,Ph.D,BethIsraelMedicalCenter.
2011–2012 Site Principal Investigator; United Hospital Fund. Health coaches—assist patients
with diabetes in managing their illness and help them navigate the health caresystem.DirectCost:$37,830.00.
2009–2011 Sponsor/Mentor;EmpireClinicalResearchInvestigatorProgram,NewYork
StateDepartmentofHealth.TheRoleofThiazolidinedionesinBoneMetabolism2008-2010 SitePrincipalInvestigator;Queens/SouthAsianActionforDiabetes
EducationProgramandTreatment(ADEPT),NewYorkStateHealthFoundation.DirectCost:$269,803.
2008–2010 Sponsor/Mentor;EmpireClinicalResearchInvestigatorProgram,NewYorkState
DepartmentofHealth.Effectsofexenatideinoverweightpatientswithpolycysticovarysyndrome(PCOS)androleofexenatideinhumanovarianregulation.
2008–2014 SitePrincipalInvestigator;Apilotrandomizedcontrolledtrialtoevaluatetheeffects
of education programs, including an interactive web site, on clinical outcomes inpatientswithdiabetes.GeraldJ.FriedmanDiabetesInstitute
2002–2014 SitePrincipal Investigator;GeraldJ.FriedmanFoundation. Receptormechanismsof
insulinandinsulin-likegrowthfactorsinovarianfunction.
LEONIDPORETSKY,M.D.
8
2004-2008 SitePrincipalInvestigator;Glaxo-SmithKline, Inc.Theeffectofthiazolidinedionesoninflammatorymarkersandoutcomesinpatientsundergoingcoronaryarterybypassgraftsurgery.
2006–2008 Sponsor/Mentor; Empire Clinical Research Investigator Program, New York State
Department of Health. Administration of Vitamin D analog to new onset type 1diabetesmellituspatientstorestorepancreaticcellfunction
2005–2007 Investigator/Mentor;EmpireClinicalResearchInvestigatorProgram,NewYorkState.
Comparisonoftheeffectoforalcontraceptiveagents,spironolactone,metforminandrosiglitazone on plasma androgen levels and clinical manifestations ofhyperandrogenesiminwomenwithpolycysticovarysyndrome.
2004–2006 Sponsor/Mentor; Empire Clinical Research Investigator Program, New York State.
VitaminDdeficiencyandinsulinresistance.2003–2005 Sponsor/Mentor; Empire Clinical Research Investigator Program, New York State.
The use of intensive insulin therapy in diabetic and non-diabetic individualsundergoingcoronaryarterybypassgraftsurgery.
2002–2004 Site Principal Investigator; Pharmacia, Inc. Role of thiazolidinediones in the human
ovary.2000–2006 Site Principal Investigator (Beth Israel Medical Center); ADOPT trial; Glaxo-Smith-
Kline,Inc.2000–2005 Co-investigator;NIHR01-MH60563.DHEAeffectsonmoodinHIVpositivepatients.
PrincipalInvestigator:JudyRabkin,Ph.D.,ColumbiaUniversity.2000–2002 Site Principal Investigator; Singer/Hellman Award. Receptormechanisms of insulin
actioninthehumanovary.1998–2000 SitePrincipalInvestigator;NICHDR035618-01A1:Receptormechanismsof insulin-
likegrowthfactorIIactionintheovary.1999–2000 Co-Investigator;N01-HC-95184(NHLBI-NIDDK)PreventionofCardiovascularDisease
inDiabetesMellitus.PrincipalInvestigator:J.ThomasBigger,M.D.,ColumbiaUniversity.1995–2000 Cornell University Medical College General Clinical Research Center, Associate Program
Director;NIHGrant#M01RR00047-35.1996–2000 Clinicaltrialofpioglitazoneindiabetes,Takeda,Inc.1997–2000 Combinationtrialofmetforminandsulfonureaindiabetes,Bristol-Myers,Inc.1987–1992 SitePrincipalInvestigator,
NIH–Grant#R29-HD22738,RoleofInsulinandInsulin-likeGrowthFactorsinOvarianFunction.
1986–1988 SitePrincipalInvestigator,
UnitedParcelServiceResearchinMedicineAward;RoleofInsulininOvarianFunction.
LEONIDPORETSKY,M.D.
9
1989–1990 SitePrincipalInvestigator,HerbertSingerCollaborativeResearchAwardatBethIsraelMedicalCenter: AnimalModelofPolycysticOvarySyndrome.
1989–1990 Co-PrincipalInvestigator,
Insulin Receptor Abnormalities in Polycystic Ovary Syndrome NIH-Grant#R01DK40605.
1989–1995 SitePrincipalInvestigator
RobertoPopeEndocrinologyResearchFundatCabriniMedicalCenter:Roleofinsulinandinsulin-likegrowthfactorsinovarianfunctions
1992–1994 SitePrincipalInvestigator,
DiabetesLengthofStayReductionProject,UnitedHospitalFundofNewYork
1992–1994 SitePrincipalInvestigator, DiabetesandMetabolismUnitProject,
FanFoxLeslieR.SamuelsFoundationRESEARCH-RELATEDACTIVITIES:1987 Member, Special Review Committee Reproductive Disorders of Women National
InstituteofChildHealthandHumanDevelopment(NICHD)1991 Member,CooperativeSpecializedInfertilityCenterProgramPanel,NICHD,NIH1992 Member, Specialized Population Research Center site visit team, University of
California,SanDiego,NICHD,NIH1992 Reviewerofgrants,MedicalResearchCouncil,UnitedKingdom1994 ReviewerofGrants,InternationalScienceFoundation1987–present Reviewerofmanuscriptsforthefollowingjournals:
JournalofClinicalEndocrinologyandMetabolism MetabolismTransplantationObesityResearchFertility&Sterility
1996–present BoardofDirectors MetropolitanDiabetesSociety NewYork,NewYork1997–present ReviewerofGrants,EndocrineFellows’Foundation1997–2008 AdvisoryBoards:
NationalDiabetesEducationInitiative(Parke-Davis)NationalEndocrinologyConsultantsInitiative(Bayer)Women’sHealthInitiative(Parke-Davis)
LEONIDPORETSKY,M.D.
10
RosiglitazoneAdvisoryBoard(Smith-Kline/Beecham)BasalInsulinAdvisoryBoard(Hoechst-Marion-Roussel)NationalACTOSAdvisoryBoard(Lilly/Takeda)DiabetesConsultantPanelMember(Aventis)
2008–2012 EditorialBoard,JournalofClinicalEndocrinologyandMetabolism2008-2018 EditorialBoard,JournalofDiabetes2010–2014 EditorialBoard,InternationalScholarlyResearchNetworkEndocrinology EditorialBoard,WorldJournalofDiabetes2014 GuestEditor,EndocrineClinicsofNorthAmerica,specialissues, “Complicationsofdiabetes”and“Diabetesanditsassociatedconditions”.2015-present SeriesEditor,“Contemporaryendocrinology”,Springer,Inc.
KöhlerTSandMcVaryKT,Editors,“Contemporarytreatmentoferectiledysfunction:Aclinicalguide”,2nded,2016,Springer,Inc.ISBN-10:3319315854.
PacakKandTaïebD,Editors,“Diagnosticandtherapeuticnuclearmedicinefor neuroendocrinetumors”,2017,Springer,Inc.DOI10.1007/978-3-319-46038-3. WintersSJandHuhtaniemiIT,Editors,“Malehypogonadism:Basic,clinicaland therapeuticprinciples”,2nded,2017,Springer,Inc.DOI10.1007/978-3-319-53298-1. LiaoEP,Editor,“ExtraskeletaleffectsofvitaminD,”2018,Springer,Inc. DOI10.1007/978-3-319-73742-3. LevineAC,Editor,“Adrenaldisorders:Physiology,pathophysiologyandtreatment,” 2018,Springer,Inc.DOI10.1007/978-3-319-62470-9. GharibH,Editor,“Thyroidnodules:Diagnosisandmanagement,”2018,Springer,Inc., DOI10.1007/978-3-319-59474-3. FreemarkMS,Editor,“PediatricObesity:Etiology,pathogenesisandtreatment,” 2018,Springer,Inc.,DOI10.1007/978-3-319-68192-4. LansbergL,Editor,“Pheochromocytomas,paragangliomasanddisordersofthe sympathoadrenalsystem,”2018,Springer,Inc.,DOI10.1007/978-3-319-77048-2. DeLeon-CrutchlowDDandStanleyCA,Editors,“Congenitalhyperinsulinism: Apracticalguidetodiagnosisandmanagement,”2019,Springer,Inc., DOI10.1007/978-3-030-02961-6. KohnB,Editor,“Pituitarydisordersofchildhood:DiagnosisandClinical Management,”2019,Springer,Inc.,DOI10.1007/978-3-030-11339-1. PoretskyLandHembreeWC,Editors,“Transgendermedicine:Amultidisciplinary approach,”2019,Springer,Inc.,DOI10.1007/978-3-030-05683-4.
LEONIDPORETSKY,M.D.
11
SELECTEDINVITEDLECTURESANDPANELS:
11th International Symposium on Immunology of Reproduction of the International CoordinationCommitteeforImmunologyofReproduction.Topic:Insulinandperoxisomeproliferators-activatedreceptor-γsignalinginthehumanovary:Basicmechanismandclinicalimplications.Varna,Bulgaria,June2-4,2006.PresentedbyDonnaSeto-Young,Ph.D.International SymposiumonPCOS inHarbinChina,August, 2006. Topic: Insulin andperoxisomeproliferators-activated receptor-γ signaling in the human ovary: Basic mechanism and clinicalimplications.PresentedbyDonnaSeto-Young,Ph.D.
GlobalHealthCareConference.Topic:Diabetes.NewYork,May22-24,2007.
SessionChair, “Androgenicdisorders inwomen,” the89thAnnualMeetingof theEndocrineSociety,Toronto,Canada,June2-5,2007.GuestExpert,“1stWorldCongressonInterventionalTherapiesforType2Diabetes,”NewYork,NewYork,September15-16,2008.VisitingProfessor,“CombinedAdult-PediatricEndocrineGrandRounds,”MattelChildrenHospitalatUCLA,DavidGeffenSchoolofMedicineatUCLA,California,September24,2008
GuestSpeaker,“ShanghaiInternationalMedicalDevelopmentForumonFamilyMedicine2012,”Shanghai,China,May10-11,2012.
DistinguishedInternationalFaculty,“8thInternationalSymposiaonDiabetes2013”,Delhi,Kolkata,Chennai,Mumbai,India,January18-26,2013.
InvitedLecturer,AmericanAssociationofClinicalEndocrinologists(AACE)PhilippinesChapter,Cebu,Philippines,August1-3,2013.InvitedLecturer,TokyoMedicalandDentalUniversity,Tokyo,Japan,December10,2013.InvitedLecturer,DepartmentofMedicineGrandRoundsatMountSinaiMedicalCenter,“PCOSUpdate2014”,NewYork,January7,2014.InvitedLecturer,CombinedMKSCC/CornellEndocrineGrandRounds,“Insulinandtheovary:Update2014”,NewYork,January8,2014.InvitedLecturer,4thInternationalCongressofGynaecologyandObstetrics2016.Topic:InsulinandtheOvary:Update2016.Barcelona,Spain,May28-30,2016.SessionChair,“Polycysticovarysyndrome,”4thInternationalCongressofGynaecologyandObstetrics2016,Barcelona,Spain,May28-30,2016.InvitedLecturer,“Pathwaytowellness:Men’shealthpanelandhealthfair,”TheUnitedNations,NewYork,NY,August29,2017.InvitedSpeaker,“HealthandSocietyRoundtable”HumanRightsConferenceforPride,SUNYGlobalCenter,NewYork,NY,June14,2018.
LEONIDPORETSKY,M.D.
12
InvitedLecturer,“AdvancesinSpecialtyCare”,multidisciplinarysymposium,Bermuda(U.K.),September15,2018.PanelLeader/Moderator,“TransgenderandSociety,”TheUnitedNations,NewYork,NY,June28,2019.
PROFESSIONALSOCIETIES:1985 AmericanDiabetesAssociation1987 InternationalDiabetesFederation AmericanAssociationfortheAdvancementofScience1988 TheEndocrineSociety1994 AmericanAssociationofClinicalEndocrinologists1996 MetropolitanDiabetesSociety,foundingBoardmemberBESTDOCTORSLISTINGS:NewYorkMagazineTheNewYorkTimesMagazineU.S.NewsandWorldReportCastleConnollyMedicalLimitedRECENTHONORSANDAWARDS:April2,2018 2018RosieAwardforadvancingdiversity;AmasMusicalTheatre49thSeasonBenefit
EventJuly30,2019 LenoxHillHospitalwasranked#9nationallyforDiabetes&Endocrinology–USNews
andWorldReport,July30,2019.ORIGINALPEER-REVIEWEDPUBLICATIONS:1. PoretskyL.Somepeculiaritiesofdiabetesmellitusinyoungobesepatients.InV.MenschikoffandV.
Spesivtseva,Eds.,ProblemsofDiabetology,Moscow,50-511977.
2. PoretskyL,SmithD,SeibelM,PazianosA,MosesAC,FlierJS.SpecificInsulinbindingsitesinhumanovary.JClinEndocrinolMetab59:809-811,1984.
3. Poretsky L, Moses A. Hypoglycemia associated with Trimethoprim/Sulfamethoxazole therapy.
DiabetesCare7:508-509,1984.
4. PoretskyL,GrigorescuF,MosesAC,FlierJS.DistributionandcharacterizationoftheinsulinandIGF-1receptorsinthehumanovary.JClinEndocrinolMetab61:728-734,1985.
LEONIDPORETSKY,M.D.
13
5. PoretskyL,LeibowitzIH,FriedmanSA.Thediagnosisofmyocardialinfarctionbycomputerderivedprotocolinamunicipalhospital.Angiology36:165-170,1985.
6. Poretsky L, Garber J, Kleefield J. Primary amenorrhea and pseudoprolactinoma in a patientwith
primary hypothyroidism: reversal of clinical, biochemical and radiologic abnormalities withlevothyroxine.AmJMed81:180-182,1986.
6. PepperGM,PoretskyL, Gabrilove JL,AritoneMM. Ketoconazole reverseshyperandrogenism in a
patient with insulin resistance and acanthosis nigricans. J Clin Endocrinol Metab 65:1047-1052,1987.
8. GatesGS,BayerS,SeibelM,PoretskyL,Flier JS,MosesAC. Characterizationof insulin-likegrowthfactorIbindingtohumangranulosacellsobtainedduringinvitrofertilization. JReceptorResearch7:885-902,1987.
9. KalinM,PoretskyL,SeresD,ZumoffB.Hyporeninemichypoaldosteronismassociatedwith
AcquiredImmuneDeficiencySyndrome.AmericanJMed82:1035-1038,1987.10. PoretskyL,BhargavaG,KalinM. Regulationof the insulinreceptors in thehumanovary(Invitro
studies).JClinEndocrinolMetab67:772-778,1988.11. Poretsky L, Lesvescue L, Smith D, Seibel M, Pazianos A, Hurd JK, Aretz HT, Flier JS.
Hyperandrogenism in a patient with a granulosa cell tumor and polycystic ovarian disease:characteristicsofinvitrosteroidogenesis.TheJournalReproductiveMed33:377-381,1988.
12. PoretskyL,GloverB,LaumasV,KalinM,DunaifA.Theeffectsofexperimentalhyperinsulinemiaon
steroid secretion, ovarian 125-I-insulin binding and ovarian 125-I-insulin-like growth factor Ibindingintherat.Endocrinology122:581-585,1988.
13. SingerF,HorlickM,PoretskyL.Recoveryofbeta-cellfunctionpostpartuminapatientwithinsulin-
dependentdiabetesmellitus.NewYorkStateJournalofMedicine9:496-498,1988.14. BhargavaG,PoretskyL,DenmanH, JandorekR,MillerLK. Hormonallyactive long-termcultureof
humanovariancells:initialcharacterization.Metabolism38:195-196,1989.15. Singer F, Bhargava G, Poretsky L. Persistent insulin resistance after normalization of androgen
levelsinawomanwithcongenitaladrenalhyperplasia.JournalReproductiveMedicine34:921-922,1989.
16. Poretsky L, Bhargava G, Levitan E. Type I insulin-like growth factor receptors in human ovarian
stroma.HormoneResearch33:22-26,1990.17. PoretskyL,BhargavaG,SaketosM,DunaifA.Regulationofhumanovarianinsulinreceptorsin-vivo.
Metabolism39:161-166,1990.18. Zumoff B, Miller L, Poretsky L, Levit C. Miller E, Heinz U, Denman H, Jandorek R, Rosenfeld R.
Subnormalfollicular-phaseserumprogesteronelevelsandelevatedfollicular-phaseserumestradiollevelsinyoungwomenwithinsulindependentdiabetes.Steroids55:560-564,1990.
LEONIDPORETSKY,M.D.
14
19. Novick D, Joseph H, Croxson S, Salsitz E, Wang G, Richman B, Poretsky L, Keefe J, Whimbey E.Absence of antibody to human immunodeficiency virus in long-term, socially rehabilitatedmethadonemaintenancepatients.ArchIntMed150:97-99,1990.
20. Battan R, Mariuz P, Raviglione MD, Sabatini MT, Mullen MP, Poretsky L. Pneumocystitis carinii
infection of the thyroid in a hypothyroid patient with AIDS: Diagnosis by fine needle aspirationbiopsy.JClinEndocrinologyMetab72:724-726,1991.
21. Poretsky L, Clemons J, Bogovich K. Hyperinsulinemia and human chorionic gonadotropin
synergisticallypromotethegrowthofovarianfollicularcystsinrats.Metabolism41:903-910,1992.22. GochuJ,PiperB,MontanaJ,ParkHS,PoretskyL.Lymphomaofthethyroidmimickingthyroiditisin
apatientwiththeAcquiredImmuneDeficiencySyndrome.JEndocrinolInvest17:279-282,1994.23. SorbaraLR,TangZ,CamaA,XiaJ,SchenkerE,KohanskiRA,PoretskyL,KollerE,TaylorSI,DunaifA.
Absenceof insulinreceptorgenemutations in three insulin-resistantwomenwithpolycysticovarysyndrome.Metabolism43:1568-74,1994.
24. Ramaprasad S, Poretsky L. Life-threatening hyponatemia due to the syndrome of inappropriate
secretion of antidiuretic hormone (SIADH) in a patient with Miller Fisher Syndrome. EndocrinePractice1:64-66,1995.
25. Rubio SI, Naha KK, Poretsky L. Coexistence of diabetes and phosphofructokinase deficiency.
EndocrinePractice2:100-102,1996.26. PoretskyL,ChandrasekherYA,GiudiceLC,BaiC,H-LLiu,RosenwaksZ. Insulinreceptormediates
inhibitory effect of insulin, but not of insulin-like growth factor (IGF)-I, on IGF binding protein 1(IGFBP-1)productioninhumangranulosacells.JClinEndocrinolMetab81:493-496,1996.
27. PoretskyL,ChunB,LiuHC,RosenwaksZ. Insulin-likegrowthfactorII(IGF-II)inhibitsinsulin-like
growth factor binding protein I (IGFBP-1) production in luteinized human granulosa cells with apotencysimilartoinsulin-likegrowthfactorI(IGF-I)andhigherthaninsulin.JClinEndocrinolMetab81:3412-3414,1996.
28. RubioSI,Sauer-PlewinskiT,SabatiniM,PoretskyL. Kikuchi’sdiseaseassociatedwithHashimoto’s
thyroiditis.JEndocrinolInvest19:136-137,1996.29. Stolarczyk R, Laufer I, Poretsky L. Absence of acanthosis nigricans in a patient with the Type B
syndromeofinsulinresistanceandpreexistingdiabetes.DiabetesCare19:885-886,1996.30. Koproski J, Pretto Z, Poretsky L. Effects of an intervention by a diabetes team in hospitalized
patientswithdiabetes.DiabetesCare20:1553-1555,1997.31. StolyarczykR,RubioS,SmolyarD,Young I,PoretskyL.24hrurinary freecortisol inpatientswith
acquiredimmunedeficiencysyndrome.Metabolism47:690-694,1998.32. PoretskyL,PrettoZ,KoproskiJ.,Lengthofstayonadiabetesclusterunit.EndocrinePractice5:66-
68,1999.33. BogovichK, Clemons J,PoretskyL. Insulinhas a biphasic effect on the ability of human chorionic
gonadotropintoinduceovariancystsintherat.Metabolism48:995-1002,1999.
LEONIDPORETSKY,M.D.
15
34. FerrandoSJ,RabkinJG,PoretskyL.Dehydroepiandrosteronesulfate(DHEAS)andtestosterone:RelationtoHIVillnessstageandprogressionoveroneyear.JournalofAcquiredImmuneDeficiencySyndromesandHumanRetrovirology22:146-154,1999.35.DamarioM,BogovichK,LiuHC,RosenwaksZ,PoretskyL.SynergisticeffectsofIGF-Iandhumanchorionicgonadotropinintheratovary.Metabolism49:314-320,2000.36. Aronoff S, Rosenblatt S, Braithwaite S, Egan JW,MathisenAL, SchneiderRL, ThePioglitazone001
StudyGroup. Pioglitazonehydrochloridemonotherapyimprovesglycemiccontrol inthetreatmentofpatientswithtype2diabetes.DiabetesCare23:1605-1611,2000.
37. PoretskyL, LesserM,BrillonD. Lackofpostprandial leptinpeaks inpatientswith type2diabetes
MelliltusDiabetes,ObesityandMetabolism3:105-111,2001.38. Poretsky L, Seto-Young D, Shrestha A, Dhillon S, Mirjany M, Liu, H-C, Yih M, Rosenwaks Z.
Phosphatidyl-inositol-3 (PI-3)-kinase-independent insulin action pathway(s) in the human ovary. JClinEndocrinolMetab86:3115-3119,2001.
39. Tolentino M, Ferenczi A, Ronen L, Poretsky L. Combination of gemfibrozil and orlistat in the
treatmentof combinedhyperlipidemiawithpredominanthypertriglyceridemia. EndocrinePractice8:3,208-212,2002.
40. SmolyarD,LandmanR,PoretskyL,YoungI.Comparisonof1µgand250µgACTHstimulationtests
fortheevaluationofadrenalfunctioninpatientswithAIDS.Metabolism52:647-651,2003.41. Seto-YoungD,ZajacJ,LiuHC,RosenwaksZ,PoretskyL.Theroleofmitogen-activatedproteinkinase
ininsulinandinsulin-likegrowthfactorI(IGF-1)signalingcascadesforprogesteroneandIGF-bindingprotein-1productioninhumangranulosacell.JClinEndocrinolMetab88:3385-3391,2003.
42. ZinmanB,KahnSE,HaffnerSM,O’NeillMC,HeiseMA,FreedMI,ADOPTStudyGroup. Phenotypic
characteristics of GAD antibody-positive recently diagnosed patientswith type 2 diabetes inNorthAmericaandEurope.Diabetes53:3193-3200,2004.
43.SalehiM,HouldenH,SheikhA,PoretskyL.Thediagnosisofadrenalinsufficiencyinapatientwith
AllgrovesyndromeandanovelmutationintheALADINgene.Metabolism54:200-205,2005.
44. Seto-YoungD,PaliouM,Schlosser J,AvtanskiD,ParkA,PatelP,HolcombK,ChangP,PoretskyL.Thiazolidinedione action in the human ovary: direct effects on steroidogenesis and insulin-likegrowthfactorbindingprotein-1(IGFBP-1)production.JClinEndocrinolMetab90:6099-6105,2005.
45. Seto-YoungD,LeonardiO,ParkA,HolcombK,SalehiM,ChangP,YihM,Rosenwaks Z, Poretsky L.
Hormonally active non-transformed human ovarian cell culture from oophorectomy specimens:methodsofdevelopmentandinitialcharacterization.HormoneResearch64:238-247,2005.
46. Poretsky L, Brillon DJ, Ferrando S, Chiu J, McElhineyM, Ferenczi A, Sison CP, Haller I, Rabkin J.
Endocrineeffectsoforaldehydroepiandrosterone(DHEA)inmenwithHIVinfection:Aprospectiverandomizeddouble-blindplacebo-controlledtrial.Metabolism55:858-870,2006.
LEONIDPORETSKY,M.D.
16
47. BrillonDJ,SisonCP,SalbeAD,PoretskyL.Reproducibiltyofaglycemicresponsetomixed mealsintype2diabetesmellitus.HormoneandMetabolicResearch38:536-542,2006.48. KahnSE,ZinmanB,HaffnerSM,O’NeillMC,HeiseMA,KravitzBG,ADOPTStudyGroup.Obesity
isamajordeterminantoftheassociationofc-reactiveproteinlevelsandthemetabolicsyndromeintype2diabetes.Diabetes55:2357-2364,2006.
49. KahnSE,HaffnerSM,HeiseMA,HermanWH,HolmanRR,ADOPTStudyGroup.Glycemicdurabilityofrosiglitazone,metformin,orglyburidemonotherapy.NEJM355:2427-2443,2006.
50. Seto-Young D, Avtanski D, Strizhevsky M, Parikh G, Patel P, Kaplun J, Holcomb K, Rosenwaks Z,
Poretsky L. Interactions among peroxisome proliferator activated receptor-γ, insulin signalingpathways,andsterodogenicacuteregulatoryproteininhumanovariancells.JClinEndocrinolMetab92:2232-2239,2007.
51.MartinezR,PoretskyL.Casestudy.Insulin2:144-145,2007.52. MartinezR,PoretskyL.Casestudyresponse.Insulin2:190-191,200753. Gurevich Y, Poretsky L. Possible prevention of hungry bone syndrome by preoperative use of
pamidronate.Otolaryngology-HeadandNeckSurgery,138:403-404,2008.
54. Kahn SE, ZinmanB, Lachin JM,Haffner SM,HermanWH,HolmanRR, Kravitz BG, YuD,HeiseMA,AftringRP,VibertiG,ADOPTStudyGroup.Rosiglitazone-associatedfracturesintype2diabetes:ananalysisfromadiabetesoutcomeprogressiontrial(ADOPT).DiabetesCare31:845-851,2008.
55. PoretskyL,SongL,BrillonDJ,FerrandoS,ChiuJ,McElhineyM,FerencziA,SisonC,HallerI,RabkinJ.MetabolicandhormonaleffectsoforalDHEAinpremenopausalwomenwithHIVinfection.HormoneandMetabolicResearch41:244-249,2009.
56. KahnSE,HaffnerSM,VibertyG,HermanWH,LachinJM,KravitzBG,YuD,Paul,G,HolmanRR,ZinmanB,ADOPTStudyGroup. RosiglitazonedecreasesC-Reactiveproteintoagreaterextentrelativetoglyburideandmetforminover4yearsdespitegreaterweightgain.DiabetesCare33:177-183,2010.
57. ZinmanB,HaffnerSM,HermanWH,HolmanRR,LachinJM,Kravitz,BG,PaulG,JonesNP,AftringRP,VibertiG,KahnSE,ADOPTStudyGroup. Effectofrosiglitazone,metformin,andglyburideonbonebiomarkersinpatientswithtype2diabetes.JClinEndocrinolMetab95:134-142,2010.
58. HomelPD,KahnSE,JonesNP,NoronhaD,Beck-NielsenH,VibertiG;ADOPTStudyGroup;RECORD
SteeringCommittee.ExperienceofmalignancieswithoralglucoseloweringdrugsintherandomizedcontrolledADOPT(ADiabetesOutcomeProgressionTrial)andRECORD(RosiglitazoneEvaluatedforCardiovascular Outcomes and Regulationof Glycaemia in Diabetes) clinical trials. Diabetologia53:1838-1845,2010.
59. PatelP,PoretskyL,LiaoE.LackofeffectofsubtherapeuticvitaminDtreatmentonglycemic
andlipidparameters inType2diabetes: ApilotProspectiverandomizedtrial. JDiabetes2:36-40,2010.
LEONIDPORETSKY,M.D.
17
60. ParikhG,VaradinovaM,SuwandhiP,ArakiT,RosenwaksZ,PoretskyL, Seto-YoungD. VitaminDregulatessteroidogenesisand insulin-likegrowth factorbindingprotein-1 (IGFBP-1)production inhumanovariancells.HormMetabRes42:754-757,2010.
61. Seto-YoungD,AvtanskiD,ParikhG,SuwandhiP,StrizhevskyM,ArakiT,RosenwaksZ,PoretskyL.Rosiglitazone and pioglitazone inhibit estrogen synthesis in human granulosa cells by interferingwithandrogenbindingtoaromatase.HormMetabRes43:250-256,2011.
62. Seto-Young D, Avtanski D, VaradinovaM, Park A, Suwandhi P, Parikh G,Poretsky L. Differential
roles of MAPK-Erk1/2 and MAPK-p38 in insulin or insulin-like growth factor-I (IGF-I) signalingpathwaysforprogesteroneproductioninhumanovariancells.HormMetabRes43:386-390,2011.
63. AbelevZ,SethA,PatelR,GoldsteinS,BogunM,PaliouM,SchlosserJ,Homel P, Busta A, Seto-Young
D, TranbaughR,Poretsky L. Continuous Insulin Infusion (CII) is associatedwith a reduced post-surgical lengthofstay(LOS),butnotthecomplicationrate, inpatientswithdiabetesmellitus(DM)undergoingCoronaryArteryBypassGraft(CABG).JEndocrInvest,34:770-774,2011.
64. Araki T, Varadinova M, Goldman M, Rosenwaks Z, Poretsky L, Seto-Young D. Rosiglitazone and
pioglitazone alter aromatase kinetic properties in human granulose cells. PPAR Research.doi:10.1155/2011/926438,2011.
65. Seth A, Sy V, Pareek A, Suwandhi P, Rosenwaks Z,Poretsky L, Seto-YoungD. Thiazolidinediones
(TZDs) affect osteoblast viability and biomarkers independently of the TZD effects on aromatase.HormMetabRes45:1-8,2013.
66. KimSJ,SyV,ArakiT,BabushkinN,HuangD,TanD,LiaoE,LiuG,WanS,PoretskyL,Seto-YoungD.Total adiponectin, but not inflammatory markers CRP, TNF-α, IL-6 and MCP-1, correlates withincreasingglucoseintoleranceinpregnantChinese-Americans.JDiabetes6:360-368,2014.
67. Pittas AG, Dawson-Hughes B, Sheehan P, Rosen C, Ware JH, Knowler WC, Staten M, The D2dResearchGroup.RationaleanddesignofthevitaminDandtype2diabetes(D2d)Study:Adiabetespreventionstudy.DiabetesCare.37:3227-3234,2014.
68. Yubero-Serrano EM, Woodward M, Poretsky L. Vlassara H, Striker GE, AGE-Less Study Group.
Effects of sevelamer carbonate on advanced glycation endproducts and anti-oxidant/pro-oxidantstatus inpatientswithdiabeteskidneydisease. Clinical JournalAmSocietyNephrology,10(5):59-66,2015.
69. Avtanski D, Hirth Y, Babushkin N, Sy V, Sharma D,Poretsky L, Seto-Young D. In Vitro effects of
pioglitazone on the expression of components of Wnt signaling pathway and markers of bonemineralization.HormMetabRes48:468-475,2016.
70. Poretsky L, Islam J, Avtanski D, Lin YK, Shen YL, Hirth Y, LesserM, Rosenwaks Z, Seto-Young D.Reproductiveeffectsofirisin:Initialinvitrostudies.ReprodBiol,17(3):285-288,2017.
71. Seto-YoungD, AvtanskiD, Kim SJ, SyV, Liao EP, LiuG,Wan S, LesserM,Poretsky L. Insulin-likegrowth factor (IGF)-I, IGF-bindingprotein (IGFBP)-1, and fibroblast growth factor (FGF)21 serumlevels inChinesewomenwith andwithout gestational diabetes. ClinObstetGynecolReprodMed,3(5):1-4,2017.
LEONIDPORETSKY,M.D.
18
72. SonmezH,KamboV,AvtanskiD,LutskyL,PoretskyL.Thereadmissionratesinpatientswithandwithout diabetesmellitus at an urban teaching hospital. J Diabetes Complications 31 (12), 1681-1685,2017.
73. TaylorJE,FishmanSL,MorrisM,KrymskayaM,GoldmanR,PoretskyL.Acaseofhyperthyroidismin
a patient using nutritional supplement “Survival Shield”. Endocrine Practice, DOI:10.4158/ACCR-2018-0086,2018.
74. AvtanskiD,GarciaA,CaraballoB,ThangeswaranP,MarinS,BiancoJ,LaviA,PoretskyL. Resistininducesbreastcancercellsepithelial tomesenchymaltransition(EMT)andstemnessthroughbothadenylyl cyclase-associated protein 1 (CAP1)-dependent and CAP1-independent mechanisms.Cytokine120:155-164,2019.
75. Pittas,AG,Dawson-HughesB,SheehanP,WareJH,KnowlerWC,ArodaVR,BrodskyI,CegliaL,Chhavi
C,ChatterjeeR,DesouzaC,DolorR,ForeytJ,FussP,GhaziA,HsiaDS,JohnsonKC,KashyapSR,KimS,LeBlanc ER, LewisMR, Liao E,Neff LM,Nelwon J, O’Neil P, Park J, PetersA, Phillips LS, PratleyR,RaskinP,RasouliN,RobbinsD,RosenC,VickeryEM,StatenM,etal.,fortheD2dResearchGroup*.Vitamin D Supplementation and Prevention of Type 2 Diabetes. NEJM, 381:520-530, 2019. DOI:10.1056/NEJMoa1900906.
76. AvtanskiD,ChenK,PoretskyL. Resistinandadenylylcyclase-associatedprotein1(CAP1)regulate
the expression of genes related to insulin resistance in BNL CL.2 mouse liver cells. Data in Brief25:104112,2019.
77. AvtanskiD,GarciaA,CaraballoB,ThangeswaranP,MarinS,Bianco J,LaviA,PoretskyL. Invitroeffectsofresistinonepithelialtomesenchymaltransition(EMT)inMCF-7andMDA-MB-231breastcancercellseqRT-PCRandWesternblotanalysesdata.DatainBrief25:104118,2019.
78. Chen K, Satlof L, Kothapalli U, Ziluck N, Lema M, Poretsky L, Avtanski D 2019 Basal cytokinesecretion in human breast cancer cells and non-carcinogenic breast epithelial cells – 41-cytokineMILLIPLEX assay data. Mendeley Data, V1, DOI: 10.17632/tvt8zm37w5.2,http://dx.doi.org/10.17632/tvt8zm37w5.2
79. Avtanski D, Pavlov VA, Tracey KJ, Poretsky L. Characterization of inflammation and insulinresistanceinhigh-fatdiet-inducedmaleC57BL/6Jmousemodelofobesity.AnimalModelExpMed.2019;00:1–7.https://doi.org/10.1002/ame2.12084.
80. AvtanskiD,ChenK,SatlofL,KothapalliU,ZiluckN,LemaM,PoretskyL.Effectofcobalt(II)chloride(CoCl2) treatmentoncytokinesecretionofhumanbreastcancercells. Data inBrief. Accepted forpublication.
81.ChenK,SatlofL,KothapalliU,ZiluckN,LemaM,PoretskyL,AvtanskiD.Cytokineexpressioninbreastcancercells–MILLIPLEXassaydata.DatainBrief,Submitted2019.
82.BasmanC,AvtanskiD,FishmanSL.RashidU,KodraA,ChenK,JonasR,StoffelsGJ,LesserM,
InlallD, ZiskovichK, SinghVP,PoretskyL. Glycosylatedhemoglobin, butnotAdvancedGlycationEnd Products, Predicts Severity of Coronary Artery Disease in Patients with or without Diabetes.JournalofCardiology.Submitted2019.
LEONIDPORETSKY,M.D.
19
REVIEWARTICLES,BOOKCHAPTERSandEDITORIALS:1. Flier JS, Poretsky L. Insulin allergy and insulin resistance. In Fauci AS, Lichtenstein LM, Eds.,
CurrentTherapyinAllergy,ImmunologyandRheumatology,1985-1986.Publishers:B.C.DeckerandC.V.MosbyP.136-140,1985.
2. PoretskyL,KalinM.Thegonadotropicfunctionofinsulin.EndocrineReviews8:132-141,1987.
3. PoretskyL,KalinM.Diabetesandovariandysfunction:whatistheconnection?TheFemalePatient
13:112-132,1988.4. Poretsky L. Insulin receptor - a potential target for pharmacological agents. Drug News and
Perspectives2:6,325-328,1989.
7. PoretskyL,MaranA,ZumoffB.EndocrinologicalandmetabolicmanifestationsofAIDS.MountSinaiJournalofMedicine57:236-241,1990.
8. Poretsky L. On the paradox of insulin-induced hyperandrogenism in insulin resistant states.
Endocrine Reviews 12:3-13, 1991. Reprinted in The Endocrine Pancreas, Insulin Action andDiabetes.ANegro-VilarandL.E.Underwood,Eds.EndocrineReviewMonographs,EndocrineSocietyPress,Bethesda,MD2:115-124,1994.
8. PoretskyL. Role of insulin resistance in thepathogenesis of thepolycystic ovaries syndrome. In:Ovarian Endocrinopathies. R. Schats, J. Schoemaker, Eds; Parthenon Publishing, London, 169-177,1994.
9. PoretskyL. Insulin resistance andhyperandrogenism:Update1994. InTheEndocrinePancreas,
InsulinActionandDiabetes:A.Negro-VilarandL.E.Underwood,Eds.EndocrineReviewsMonograph;EndocrineSocietyPress,Bethesda,MD,2:125-129,1994.
10. Poretsky L, Piper B. Dual defect hypothesis of the polycystic ovaries syndrome. Obstetrics and
Gynecology84:613-621,1994.11. PoretskyL,CanS,ZumoffB.Testiculardysfunctioninhumanimmunodeficiencyvirusinfectedmen.
Metabolism,Vol44,7:946-953,1995.12. KoproskiJ,PrettoZ,PoretskyL.Hospitalmanagementofpatientswithdiabetesinpost-DCCTera.
PracticalDiabetology14:2-7,1995.
13. PoretskyL,PastorC.Physicianreviewersandconflictofinterest,Editorial.TheEndocrinologist:5:85-86,1995.
14. PoretskyL,CataldoN,RosenwaksZ,GuidiceL.Insulin-relatedovarianregulatorysysteminhealth
anddisease.EndocrineReviews20:535-582,1999.15. PoretskyL.Polycysticovarysyndrome(bookreview).JClinEndocrinolMetab86:2402,2001.16.BloomgardenZ,FutterweitW,PoretskyL.Useofinsulinsensitizingagentsinpatients withpolycysticovarysyndrome.EndocrinePractice7:279-286,2001.
LEONIDPORETSKY,M.D.
20
17. Tolentino M, Zweig, SB, Poretsky L. Polycystic ovarian syndrome. In: “Principles of Diabetes
Mellitus”,pp701-721,L.Poretsky,Ed.KluwerAcademicPublishing,Boston,MA,2002.18. ZajacJ,ShresthaA,PoretskyL.Themaineventsinthehistoryofdiabetesmellitus.In:“Principlesof
DiabetesMellitus”,pp19-37,L.Poretsky,Ed.KluwerAcademicPublishing,Boston,MA,2002.19. SalehiM,Bravo-VeraR,SheikhA,GoullerA,PoretskyL.Obesityinpolycysticovary
syndrome: Two diseases or one? Turkish Journal of Endocrinology and Metabolism 4:149-157,2003.
20. SalehiM,Bravo-VeraR,SheikhA,GoullerA,PoretskyL.Pathogenesisofpolycysticovarysyndrome:Whatistheroleofobesity?Metabolism53:358-376,2004.
21. LiaoEP,PoretskyL.Polycysticovarysyndromeanditsmetaboliccomplications.
In"ObesityandDiabetes",pp255-276.C.Mantzoros,Ed.,HumanaPress,Totowa,NJ,2006.
22. PoretskyL.Polycysticovarysyndrome:Increasedorpreservedovariansensitivitytoinsulin?JClinEndocrinolMetab91:2859-2860,2006.
23. LevineP,KaplunJ,ShavelsonD,PoretskyL. Thepre-Charcotfoot:AnewclinicalentitytopreventCharcotjointdisease.PracticalDiabetology25:24-28,2006.
24. AlfonsoB,LiaoEP,BustaA,PoretskyL.TheroleofvitaminDindiabetesmellitus—anewfieldofknowledgepoisedforD-velopment.Diabetes/MetabolismResearchandReviews25:417-419,2009.
25. Zweig,SB,TolentinoMC,StrizhevskyM,PoretskyL.Polycysticovarysyndrome.In:“Principlesof
DiabetesMellitus”,pp515-530,2ndedition,L.Poretsky,Ed.Springer,NewYork,2010.
26. Zajac J, Shrestha A, Patel P, Poretsky L. The main events in the history of diabetes mellitus. In:“PrinciplesofDiabetesMellitus”,pp3-16,2ndedition,L.Poretsky,Ed.Springer,NewYork,2010.
27. BrassBJ,AbelevZ,LiaoEP,PoretskyL.EndocrinePancreas.In:“PrinciplesofDiabetesMellitus”,pp37-55,2ndedition,L.Poretsky,Ed.Springer,NewYork,2010.
28. PoretskyL. PrefaceII. In: “PrinciplesofDiabetesMellitus”,2ndedition,L.Poretsky,Ed. Springer,
NewYork,2010.
29. Romero CM, Liao EP, Zumoff B, Poretsky L. Dehydroepiandrosterone (DHEA) in HumanImmunodeficiencyVirusInfection:PrognosticandTherapeuticAspects.In:“DHEAinHumanHealthandAging”,pp195-205.R.Watson,Ed.,CRCPress,BocaRaton,FL,2011.
30. Araki T, Abdallah R, Rosenwaks Z,Poretsky L. Achieving a successful pregnancy inwomenwith
PCOS.EndocrinologyandMetabolismClinicsofNorthAmerica,40:865-894,2011.31. AlfonsoB,PoretskyL,BustaA.RoleofVitaminDinthepathogenesisandtherapyoftype1
diabetesmellitus. In: “Type1Diabetes/Book3”,CPLiu,Ed.,InTechOpenAccessPublisher,Rijeka,Croatia,2011.
32. PoretskyL.“StopthesovietizationofAmericanmedicine,”Op/Ed,Forbes.com,July3,2012.
LEONIDPORETSKY,M.D.
21
33.PoretskyL.Lookingbeyondovernutritionforcausesofepidemicmetabolicdisease.Proceedingsof
theNationalAcademyofSciencesoftheUnitedStatesofAmerica.39:15537-15538,2012.34. Poretsky L. The sovietization of American medicine: Notes from the front lines. Journal of AmericanPhysiciansandSurgeons,18(2),2:50-54,2013.35.LiaoE,PoretskyL.Whyfocusoncomplications?EndocrinologyandMetabolismClinicsofNorth America,42:657-1014,2013.36. NandiA,PoretskyL.Diabetesandthefemalereproductivesystem.EndocrinologyandMetabolism
ClinicsofNorthAmerica,42:915-946,2013.37. LiaoE,BustaA,PareekA,PoretskyL.Newapproachtopreventingandtreatingdiabetes mellitus:
Focusonadvancedglycationendproducts(AGE). In: “Frontiers inclinicaldrugresearch-diabetesandobesity”,Atta-Ur-Rahman,FRS,Ed.,pp33-36,BenthamScience,TheNetherlands,2014.
38. Liao EP, Poretsky L. Associated conditions: Why are they important? Endocrinology and
MetabolismClinicsofNorthAmerica,43:1,xvii-xviii,2014.39. Nandi A, Chen Z, Patel R, Poretsky L. Polycystic ovary syndrome. Endocrinology and MetabolismClinicsofNorthAmerica,43:1,123-147,2014.40. Nandi A, Sinha N, Ong W, Sonmez E, Poretsky L. Is there a role for Vitamin D in human
reproduction?HormMolBiolClinInvest,25(1):15-28,2016.
41. SonmezH,KamboV,TahaR,PoretskyL.Reducinghospitalreadmissionsinpatientswithdiabetes:Developingbetterstrategies.EndocrPract,22:9,1134-1136,2016.DOI:10.4158/EP161315.CO.
42. Goldman R, Zajac J, Shrestha A, Patel P,Poretsky L. The main events in the history of diabetes
mellitus. In: “Principles of DiabetesMellitus”, pp 3-19, 3rd edition, L. Poretsky, Ed. Springer, NewYork,2017.
43. LiaoEP,PoretskyL.EndocrinePancreas.In:“PrinciplesofDiabetesMellitus”,pp43-55,3rdedition,
L.Poretsky,Ed.Springer,NewYork,2017.44. Sood M, Zweig S, Tolentino M, Strizhevsky M, Poretsky L. Polycystic ovary syndrome. In:
“PrinciplesofDiabetesMellitus”,pp659-677,3rdedition,L.Poretsky,Ed.Springer,NewYork,2017.45. FishmanSL,SonmezH,SinghV,AvtanskiD,NandiA,MabagosG,PoretskyL. “AdvancedGlycation
End-Products and coronary artery disease in patients with and without diabetes: A review.”MolecularMedicine,24:59,2018.DOI:10.1186/s10020-018-0060-3.
46. AvtanskiD,PoretskyL.Phyto-polyphenolsaspotentialinhibitorsofbreastcancermetastasis.
MolecularMedicine.MolecularMedicine24(1):29-45,2018.47. ColonD,GoldsteinS,PoretskyL.Resourcesfortransgenderindividuals:Transgenderorganizations
andservices. In: “Transgendermedicine–Amultidisciplinaryapproach”,pp377-462,L.PoretskyandW.Hembreeeditors,Springer,NewYork,2019.
LEONIDPORETSKY,M.D.
22
48. FishmanSL,PaliouM,PoretskyL,HembreeW.Endocrinecareoftransgenderadults.In:
“Transgendermedicine–Amultidisciplinaryapproach”,pp143-163,L.PoretskyandW.Hembreeeditors,Springer,NewYork,2019.
BOOKS:1. Principlesofdiabetesmellitus,1stedition.L.Poretsky,editor.KluwerAcademicPublishing,Boston,
MA,2002.
2. Principlesofdiabetesmellitus,2ndedition.L.Poretsky,editor.Springer,NewYork,2010.3. Conciseguidetodiabetes.L.Poretsky,editor.Springer,NewYork,2012.
4. Principlesofdiabetesmellitus,3rdedition.L.Poretsky,editor.Springer,NewYork,2017.
5. Transgendermedicine-Amultidisciplinaryapproach,1stedition.L.PoretskyandW.Hembree
editors.Springer,NewYork,2019.
ABSTRACTSPRESENTEDATNATIONALANDINTERNATIONALMEETINGS:1. Poretsky L, SmithD, SeibelM,Moses AC, Flier JS. Specific insulin receptors in the human ovary:
possible mediators of hyperandrogenism in insulin resistant states. Proceedings of the 23rdScientificMeetingontheMass.AffiliateAmericanDiabetesAssociation,Boston,Mass.,1984p.16.
2. PoretskyL,GrigorescuF,FlierJS.InsulinbutnotIGF-Ireceptorsarewidelydistributedinthe
humanovaries.Presentedatthe67thAnnualMeetingoftheAmericanEndocrineSociety,A814,p.204,1985.
3. SeibelMM,PoretskyL,GrigorescuF,MosesAC,FlierJS.Thedistributionofinsulinreceptorsinthehuman ovary. Presented at the 41st AnnualMeeting of the American Fertility Society, A76, p.42,1985.
4. KalinM,PoretskyL,SeresD,ZumoffB.Hyporeninemichypoaldosteronismassociatedwithacquiredimmune deficiency syndrome. Presented at the 68th Annual Meeting of the American EndocrineSociety,A680,p.201,1986.
5. KalinM.PoretskyL,SeersD,ZumoffB.Hyporeninemichypoaldosteronismassociatedwithacquiredimmune deficiency syndrome. Presented at the 68th annual meeting of the American College ofPhysicians,A26April2-5,1987.
6. SingerF,HorlickM,PoretskyL.RecoveryofBeta-CellFunctionPostpartuminanInsulinDependent
Diabetic.Materialsofthe47thAnnualMeetingoftheAmericanDiabetesAssociation,A823June7-9,1987.
7. PoretskyL,GloverB,LaumasV,KalinM,DunaifA.Regulationofovarianinsulinreceptor,IGF-1receptors,andaromataseactivitybyexperimentalhyperinsulinemiainvivoClinicalResearch.35:401A,1987.
LEONIDPORETSKY,M.D.
23
8. PoretskyL, BhargavaG,KalinMF,Wolf S, JimenesGJS, SolisOG. In vitro regulation of Insulin
receptors in the human ovary. A686 70th AnnualMeeting of the Endocrine Society; NewOrleans,1988.
9. Singer F, Poretsky L. Insulin Resistance persists after normalization of androgens in congenital
adrenalhyperplasia.48thAnnualMeetingoftheAmericanDiabetesAssociation,A579,NewOrleans,June11-14,1988.
10. PoretskyL, BhargavaG, KalinMF,Wolf S, JimenesGJS, SolisOG. In vitro regulation of insulin
receptorsinthehumanovary.13thInternationalDiabetesFederationCongress,Sydney,Australia,A002-015,1988.
11. PoretskyL,BhargavaG,SaketosM,DunaifA.Regulationofhumanovarianinsulinreceptorsin-vivo.
Presentedatthe71stAnnualMeetingoftheEndocrineSociety,SeattleWA,A894,1989.12. Poretsky L, Clemons J, Bogovich K. Effects of hyperinsulinemia on the induction of rat ovarian
follicular cysts by human chorionic gonadotropin. 73rd Annual Meeting of the Endocrine Society,WashingtonDC,A354,1991.
13. KoproskiJ,PrettoZ,PoretskyL.TheeffectoftheDiabeticUnitandtheDiabetesTeamonthelength
ofstayofpatientswithdiabetesinthehospital.Presentedatthe54thAnnualAmericanDiabetesAssociationMeeting,NewOrleans,LA,A97,1994.
14. ChandrasekherYA,GiudiceLC,BaiC,LiuH-L,RosenwaksZ,PoretskyL.Insulinandinsulin-like
growthfactorI(IGF-I)inhibitIGFbindingproteinI(IGFBP-I)productionbyhumangranulosa-lutealcells(hGCs).AmericanFertilitySocietyMeeting,p.159,1994.
15. PoretskyL.Insulinresistanceandthepolycysticovarysyndrome.StraubPacificHealthFoundation
Symposium,Honolulu,HI,November3-4,1994.
16. KoproskiJ,PrettoZ,PoretskyL. Theeffectsofdiabetesinitiativeinanacutecaresetting.GreaterNewYorkHospitalFoundation,Inc.AndUnitedHospitalFundofNewYork,1994AnnualSymposiumonHealthServicesResearch,NewYork,NY,November,1994.
17. PoretskyL, ChandrasekherYA,BaiC, LiuHC,RosenwaksZ, SiddleK,GiudiceL. Insulin and IGF-I
inhibit IGF binding protein I (IGFBP-I) production in human granulosa cells via their respectivereceptors.TheEndocrineSocietyMeeting,Washington,DC,P3-219,1995.
18. Koproski J, Pretto Z, Poretsky L. Effects of the multidisciplinary approach to patients with
diabetes mellitus in an acute care teaching hospital. American Diabetes Association Meeting,President’spostersession,Atlanta,GA,A596,1995.
19. ClarkC.R.,KimE.,ChandrasekherY.A.,MartinaN.A,PoretskyL,GiudiceL.D.Twodistinctisoforms
of IGFBP-1 are found in luteinized granulosa cell conditioned media from IVF patients. 10thInternationalCongressofEndocrinology,SanFrancisco,CA,P3-394,1996.
20. BogovichK.,Clemons,PoretskyL.Theeffectsofincreasingdosesofhumanchorionicgonadotropin
and insulin on ovarian morphology and plasma sex steroid concentrations in the rat. 10thInternationalCongressofEndocrinology,SanFrancisco,CA,P3-317,1996.
LEONIDPORETSKY,M.D.
24
21. ChunB.,LiuH.C.,RosenwaksZ.,PoretskyL.Insulin-likegrowthfactorII(IGF-II)inhibitsinsulin-likegrowthfactorbindingproteinII(IGFBP-I)productioninhumangranulosecells(HGC)withthepotencysimilartoIGF-Iandhigherthaninsulin.10thInternationalCongressofEndocrinology,SanFrancisco,CA,P2-256,1996.
22. DamarioM.,Bogovich,LiuH.C,MandelL,RosenwaksZ,PoretskyL.Evidencethatinsulin-like
growth factor I (IGF-I) acts synergistically with human chorionic gonadotropin (hCG) for theinduction of large ovarian cysts in the rat. 10th International Congress of Endocrinology, SanFrancisco,CA,P1-303,1996.
23. Bogovich K , Wheeler B, Russell R , Rosenwaks Z,Poretsky L. Induction of ovarian cysts in theZuckerrat.TheEndocrineSocietyMeeting,Minneapolis,MNP-389,1997.
24. Stolarczyk R, Rubio S, Young I,Poretsky L. 24 hr urinary free cortisol levels and plasma cortisol
responsestoACTHinAIDS.TheEndocrineSocietyMeeting,Minneapolis,MN,P-309,1997.25. YahampathN,PatelR,RaoR,FarkouhT,SalbeA,PoretskyL.Glycemicindexofamixedmeal(GIMM)
inNIDDM. 57thAnnualMeetingoftheAmericanDiabetesAssociation,A-1107,P289A,BostonMA,1997.
26. ManzoorA,LeeE,BrillonD,SalbeA,PoretskyL. Glycemic indexofamixedmeal (GIMM) in type
2DM.58thAnnualmeetingoftheAmericanDiabetesAssociation,0327,PA-84,Chicago,1998.27. Poretsky L, Brillon D. Circulating leptin levels do not change postprandially in patients with type 2 diabetes mellitus (DM) who are not on insulin therapy. 80th Annual Meeting of the EndocrineSocietyP3-389,P466,NewOrleans1998.29. SmolyarD,LandmanR,PoretskyL,YoungI.Comparisonof1µgACTHstimulationtestsforthe
evaluationofadrenalfunctioninpatientswithAIDS.80thAnnualMeetingoftheEndocrineSociety,P2-389,P332,NewOrleans,1998.
30. Bogovich K, Bissada M, ReidWP, Wheeler BB, Rosenwaks Z, Poretsky L. Differences in ovarianresponses of lean and obese adult Zucker rats to prolonged stimulation by ubovulatory doses ofhumanchorionicgonadotropin(hCG):potentialeffectofhyperinsulinemiaonthegrowthofovariancysts.81stAnnualEndocrineSocietyMeeting,OR11-2SanDiego,1999.
31. PoretskyL,AndersonR,KynerJandMertenJ.Incidenceofhypoglycemia(fingerstickbloodglucose<50mg/dL)withmetformin/glyburide. Abstract 494. 60th AnnualMeeting of AmericanDiabetesAssociation,SanAntonio,Texas,June9-13th,2000.
32. Poretsky L,Mooradian A, Buse J, Kyner J andHenryD. Effect ofmetformin/glyburide tablets onlacticacidinpatientswithtype2diabetes.Abstract1523.60thAnnualMeetingofAmericanDiabetesAssociation,SanAntonio,Texas,June9-13th,2000.
33. Poretsky L, Dhillon S, Yih M, Liu HC, and Rosenwaks Z. Evidence for a PI-3 kinase independentinsulinactionpathwayintheovary,Abstract#564,82ndAnnualEndocrineSocietyMeeting,Toronto,Canada,June21-24,2000.
LEONIDPORETSKY,M.D.
25
34. Tolentino M, Poretsky L. Combination of Gemfibrozil and Orlistat in the treatment of severehypertriglyceridemia in a non-diabetic, non-obesemale. Annual Meeting, American Association ofClinicalEndocrinologists,Abstract#65,SanAntonio,Texas,May2-6,2001.
35. ZajacJ,FleckmanA,PoretskyL.Mitralandtricuspidregurgitationwithmitralvalveprolapseand
congestiveheartfailurecomplicatingGraves’disease.AnnualMeetingoftheAmericanAssociationofClinicalEndocrinologists,Abstract#49,SanAntonio,Texas,May2-6,2001.
36. PoretskyL,Seto-YoungD,ShresthaA,LiuH-C,YihM,RosenwaksZ.Humangranulosecells(HGC)possessPI-3kinase-independentinsulinactionpathway(s)whichregulateprogesteroneandIGFBP-1 production, Abstract #P2-392, 83rd Annual Meeting of the Endocrine Society, Denver, Colorado,June2-24,2001.
36. ZajacJ,BranovanD,SuslinaI,PoretskyL.Prevalenceofanti-thyro-peroxidaseAntibodies(anti-TPO-
Ab) in subjects exposed in childhood to Chernobyl fallout. Poster accepted forAnnualMeeting ofAmericanAssociationofClinicalEndocrinologists,Chicago,IL,May1-5,2002.
37. Zajac J, Salehi M, Bloomgarden B, Cohen R, Tranbaugh R, Poretsky L. Glycemic control and thelength of stay after coronary artery bypass grafting (CABG). 62nd Annual Meeting of AmericanDiabetesAssociation,704-P,SanFrancisco,CA,June14-18,2002.
38. Salehi M, Gouller A, Poretsky L. Acute leukopenia as manifestation of severe thyrotoxicosis in a
patientwithGraves’disease.Poster#P3-650,EndocrineSociety84thAnnualMeeting,SanFrancisco,CA,June19-22,2002.
39. Seto-YoungD, Zajac J, LiuHC,Rosenwaks Z,PoretskyL. Mitogen activatedprotein kinase (MAP-kinase)independenteffectofinsulininhumangranulosacells.84thAnnualMeetingoftheEndocrineSociety,P2-452,SanFrancisco,CA,June19-22,2002.
40. ZweigS,RabkinJ,FerrandoS,BrillonD,PoretskyL.EndocrineeffectsoforalDHEAadministration.
84thAnnualMeetingoftheEndocrineSociety,P1-399,SanFrancisco,CA,June19-22,2002.41. Bravo-Vera R,Poretsky L, Fleckman A. Primary hyperparathyroidism and nonmedullary thyroid
cancer. 12th Annual Meeting and Clinical Congress of the American Association of ClinicalEndocrinologists,Abstract49,SanDiego,CA,May14-18,2003.
42. SalehiM,Poretsky L. Challenging diagnosis of adrenocorticotropin insensitivity in a patientwith
Allgrove’s syndrome, 12th Annual Meeting and Clinical Congress of the American Association ofClinicalEndocrinologists,Abstract#62,SanDiego,CA,May14-18,2003.
43. FerencziA,SheikhA,PoretskyL,FleckmanA.Misleadingelevationsofurinaryfreecortisol
measurementsinthediagnosticevaluationofCushing’sSyndrome.12thAnnualMeetingandClinicalCongressoftheAmericanAssociationofClinicalEndocrinologists,Abstract#48,SanDiego,CA,May14-18,2003.
44. SalehiM,PaparsenosA,FerencziA,VecchioJ,ThakurS,CohenB,TranbaughR,LesserM,BustaA,PoretskyL.Theimpactofglycemiccontrolonthelengthofstay(LOS)aftercoronaryarterybypassgrafting surgery (CABG). Abstract #2048-PO, American Diabetes Association 63rd ScientificSession,NewOrleans,LA,June13-17,2003.
LEONIDPORETSKY,M.D.
26
45. Seto-YoungD,SalehiM,ChidakelA,ZajacJ,YihM,ChangP,PoretskyL.Initialcharacterizationofashort-termhumanovariancellculture.85thAnnualMeetingoftheEndocrineSociety,P1-692,Philadelphia,PA,June19-22,2003.
46. Seto-YoungD,ZajacJ,SalehiM,KaplunJ,FeldmanD,Hung-ChingL,RosenwaksZ,PoretskyL.TheroleofmitogenactivatedproteinkinaseininsulinandIGF-1signalingcascadesfor progesteroneandIGFBP-1productioninhumangranulosecells.85thAnnualMeetingoftheEndocrineSociety,P3-33,Philadelphia,PA,June19-22,2003.
47. FerencziA,ChiuJ,SisonC,FerrandoSJ,BrillonD,RabkinJG,PoretskyL.Metabolicandhormonal
effectsoforalDHEAinHIV+men.85thAnnualMeetingoftheEndocrineSociety,P3-615,Philadelphia,PA,June19-22,2003.
48. PaliouM,LiaoE,SchlosserJ,PoretskyL.Metformin-associatedlacticacidosis.13thAnnualMeetingandClinicalCongressoftheAmericanAssociationofClinicalEndocrinologists,Abstract#37,Boston,MA,April28-May2,2004.
49. SheikhA,SchlosserJ,Bravo-VeraR,NarasimhanG,PoretskyL.FalselylowhemoglobinA1clevelsin
a patient with diabetes mellitus, hepatitis C and HIV infection. Abstract #2405-PO, AmericanDiabetesAssociation64thAnnualMeeting,Orlando,Fl,June4-8,2004.
50. Seto-Young D, Leonardi O, Holcomb K, Kaplun J, Omry G, Park A, Levy E, SalehiM, Bravo-Vera R,
SheikhA,ChangP,PoretskyL. Characterizationofanon-transformedhumanovariancellculture:Regulationofsteroidogenesisbygonadotropinsand insulin. 86thAnnualMeetingof theEndocrineSociety,P1-250,NewOrleans,LA,June16-19,2004.
51. PaliouM,SchlosserJ,AbelevZ,PaparsenosA,Seto-YoungD,SalehiM,BustaA,PoretskyL.Impactof
intravenous insulin infusion (III) on length of stay (LOS) and post-operative complications in 438patientswithdiabetes(DM)undergoingcoronaryarterybypassgraft(CABG).86thAnnualMeetingoftheEndocrineSociety,P1-332,NewOrleans,LA,June16-19,2004.
52. ParkA,PoretskyL,HolcombK,ChangP,Seto-YoungD.Effectsofrosiglitazoneonhumanovarian
steroidogenesisandIGFBP-1productioninvitro.52ndAnnualMeetingSocietyforGynecologicInvestigation,Abstract#16,LosAngeles,CA,March2005.
53. KaplunJ,LiuL,PoretskyL.Erythrocytosisasapresentingfeatureofacromegaly.14thAnnualMeetingandClinicalCongressoftheAmericanAssociationofClinicalEndocrinologists,Abstract#742,Washington,DC,May18-22,2005.
54. PaliouM,Schlosser J,PoretskyL. Situs inversus total isassociatedwithSR⎜ gene translocation to
AM chromosome in a 46 male. 14th Annual Meeting and Clinical Congress of the AmericanAssociationofClinicalEndocrinologists,Abstract#777,Washington,DC,May18-22,2005.
55. Liu L, Kaplun J, Paliou M, Schlosser J,Poretsky L. Falsely low HgbA1c in patients with diabetes
mellitusandHIVinfection.87thAnnualMeetingoftheEndocrineSociety,P3-418,SanDiego,CA,June4-7,2005.
LEONIDPORETSKY,M.D.
27
56. Seto-YoungD,PaliouM,SchlosserJ,PatelP,ParkA,AvtanskiD,LatifW,BabarN,YeshouD,OmryG,HolcombK,PoretskyL.Peroxisomeproliferatoractivatedreceptor-γ(PPAR-γ)inhumanovariancells:ItsroleinregulationofsteroidogenesisandIGFBP-1production.87thAnnualMeetingoftheEndocrineSociety,P3-564,SanDiego,CA,June4-7,2005.
57. PaliouM,SchlosserJ,KaplunJ,SisonC,FerrandoSJ,BrillonDJ,RabkinJG,PoretskyL.MetabolicandhormonaleffectsoforalDHEAinpremenopausalwomenwithHIVinfection.87thAnnualMeetingoftheEndocrineSociety,P3-567,SanDiego,CA,June4-7,2005.
58. Saliby A, Brass B, Seto-Young D, Tranbaugh R, Poretsky L. The effects of glucose-insulin- potassium(GIK)infusionontheoutomesofcoronaryarterybypassgraft.Abstract#2157- PO, AmericanDiabetesAssociation65thAnnualMeeting,SanDiego,CA,June10-14,2005.59. PaliouM, Schlosser J,AbelevZ, SalehiM,PaparsenosA,BustaA, LesserM,PoretskyL. Impact of
glycemic control with intravenous insulin infusion (III) or subcutaneous insulin (SCI) on post-operative complications in diabetic patients undergoing coronary artery bypass graft (CABG).Abstract#2569-PO,AmericanDiabetesAssociation65thAnnualMeeting,SanDiego,CA,June10-14,2005.
60. SongL,HeringBJ,PoretskyL.Clinicalcourseofapatientwithisletcelltransplant.15thAnnualMeeting and Clinical Congress of the American Association of Clinical Endocrinologists, Abstract#319,Chicago,IL,April26-30,2006.
61. Seto-YoungD, AvtanskiD,Poretsky L. Insulin and peroxisomeproliferators- activated receptor-γsignaling in the human ovary: Basic mechanism and clinical implications. 11th InternationalSymposium on Immunology of Reproduction of the International Coordination Committee forImmunologyofReproduction,Varna,Bulgaria,June2-4,2006.
62. AvtanskiD,KaplunJ,StrizhevskyM,ParkA,PatelP,KantorY,BrownMK,DhillonS,MoosavyA,Pang
X, Akhtar MJ, Goldman M, Yeshou D, Holcomb K, Rosenwaks Z, Seto-Young D, Poretsky L.InteractionsamongPPAR-γ, insulinsignalingpathwaysandaromataseinhumanovariancells. 88thAnnualMeetingoftheEndocrineSociety,P1-397,Boston,MA,June24-27,2006.
63.AvtanskiD,ParkA,KaplunJ,StrizhevskyM,KantorY,HolcombK,PoretskyL,Seto-YoungD.Effectsofmitogen-activatedproteinkinase(MAPK)inhibitiononprogesteroneandinsulin-like
growthfactorbindingprotein-1(IGFBP-1)productioninhumanovariancells.88thAnnualMeetingoftheEndocrineSociety,P1-409,Boston,MA,June24-27,2006.
64. PatelP,Seto-YoungD,PoretskyL,LiaoEP.EffectsofvitaminDsupplementationintype2diabetesmellitus.88thAnnualMeetingoftheEndocrineSociety,P2-506,Boston,MA,June24-27,2006.
65. SalibyAH,StachelMW,SantosEM,Seto-YoungD,ZonzseinJ,TranbaughR,PoretskyL.Theeffectofglucose-insulin-potassium infusion and rosiglitazone on the clinical outcome and the circulatinglevelsoffreefattyacidsinpatientsundergoingcoronaryarterybypassgrafting.88thAnnualMeetingoftheEndocrineSociety,P3-659,Boston,MA,June24-27,2006.
66. GurevichY,PoretskyL.Canpamidronatepreventhungrybonesyndromeafterparathyroidectomy?
16thAnnualMeetingandClinicalCongressoftheAmericanAssociationofClinicalEndocrinologists,Abstract#393,Seattle,WA,April11-15,2007.
LEONIDPORETSKY,M.D.
28
67. AvtanskiDB,StrizhevskyM,ParikhG,ArakiT,RosenO,DemetriC,GoldmanM,CadaqS,RosenwaksZ,PoretskyL,Seto-YoungD.Theeffectofthiazolidinedionesonestrogenproductioninhumangranulosecells.89thAnnualMeetingoftheEndocrineSociety,P1-317,Toronto,Canada,June2-5,2007.
68.SongL,Seto-YoungD,LiuL,PoretskyL.Lackofconsistenteffectofinsulin-likegrowthfactorI(IGF-
1)onplasminogenactivatorinhibitortype1(PAI-1)productioninculturedhumanaorticendothelialcells(HAEC).89thAnnualMeetingoftheEndocrineSociety,P3-389,Toronto,Canada,June2-5,2007.
69. MartinezRE,PoretskyL,LamA,KrymskayaM,BurkeG.Diabeteseducationforthedeaf: unexploredterritory.16thAnnualMeetingandClinicalCongressoftheAmericanAssociationof ClinicalEndocrinologists,Abstract#272,Seattle,WA,April11-15,2007.70. BernsteinG,PoretskyL,LamA,KrymskayaM,DeJesusJ,DoyleR,BurkeG,ToweM,WorthingtonB.
Culturally CompententDiabetes Education Program forDeaf Patients. 34th AnnualMeeting of theAmericanAssociationofDiabetesEducators,AbstractCQ01,St.Louis,MO,August1-4,2007.
71. AvtanskiDB,ParikhG,StrizhevskyM,FengY,PareekA,SinghJ,SinghN,PolskayaM,RosenwaksZ,
Seto-Young D, Poretsky L. Thiazolidinediones inhibit estrogen synthesis by interfering withandrogenbindingtoaromatase.90thAnnualMeetingoftheEndocrineSocietyMeeting,AbstractP2-44,SanFrancisco,CA,June15-18,2008.
72. ParikhG,ChlamtacN,RosenwaksZ,PoretskyL,Seto-YoungD.VitaminDreceptor(VDR)is
expressed inhumanovariancells, likelymediating theeffectsofVitaminDon testosterone (T)andprogesterone (P) production. 90th AnnualMeeting of the Endocrine SocietyMeeting, Abstract P2-468,SanFrancisco,CA,June15-18,2008.
73. Poretsky L, DeJesus J, Lam A, Krymskaya M, Mantha K, Burke G. The effects of diabetes self-
managementeducationonHbA1Cindeafpatients.68thScientificSessionsoftheAmericanDiabetesAssociation,Abstract861-P,SanFrancisco,CA,June6-10,2008.
74. AbelevZ,SethA,PatelRR,GoldsteinS,BogunMM,HomelP,BustaA,PoretskyL.Intravenousinsulin
infusion(III),24hrpostoperativecapillarybloodglucose(CBG)andpatientage affect post-surgicallengthofstay(LOS)andcomplicationsinpatientswithdiabetesmellitus(DMundergoingcoronaryarterybypassgraft (CABG). 69thScientificSessionsof theAmericanDiabetesAssociation,Abstract692-P,NewOrleans,LA,June5-9,2009.
75. CadagS,KrymskayaM,DeJesusJ,SrivastavaA,CraigW,RegesterJ,LevineR,MorrowN,PoretskyL.
The effects of a diabetes education program on clinical outcomes in patients with diabetes. 69thScientificSessionsoftheAmericanDiabetesAssociation,Abstract911-P,NewOrleans,LA,June5-9,2009.
76. ArakiT,GoldmanM,VaradinovaM, JoshiP,ChaanineA,SethA,FengY,RosenwaksZ,PoretskyL,
Seto-Young D. The effects of thiazolidinediones (TZD) on aromatase enzyme kinetics in humangranulosecells.91stAnnualMeetingoftheEndocrineSociety,AbstractP3-268,Washington,DC,June10-13,2009.
77. CadagS,KrymskayaM,DeJesusJ,SrivastavaA,CraigW,RegesterJ,LevineR,MorrowN,
Poretsky L. The effects of a diabetes education program on clinical outcomes in patients withdiabetes.36thAnnualMeetingof theAmericanAssociationofDiabetesEducators,Abstract153019,AtlantaGeorgia,August5-8,2009.
LEONIDPORETSKY,M.D.
29
78. SethAK,GajzerDC,SuwandhiP,FengY,KatoS,RomeroC,PatelR,RosenwaksZ,PoretskyL,Seto-
YoungD.Thiazolidinediones(TZDs)InhibitBoneTurnover.92ndAnnualMeetingoftheEndocrineSociety,AbstractP2-184,SanDiego,CA,June19-22,2010.
79. CadagS,PatelR,KahanJ,LiaoEP,PoretskyL.Latentautoimmunediabetesinadults(LADA)with
hightitersofGAD65antibodiesbutlackoflong-terminsulindependence.92ndAnnualMeetingoftheEndocrineSociety,AbstractP3-560,SanDiego,CA,June19-22,2010.
80. ParikhG,Mantha-ThalerK,AyinikalA,PandyaS,JoshiP,HomelP,PoretskyL.Actionfor
DiabetesEducationProgramandTreatment(ADEPT):AnoutreachprogramforSouthAsianpatientswithdiabetes.70thScientificSessionsoftheAmericanDiabetesAssociation,Abstract1032-P,Orlando,FL,June25-29,2010.
81. DeJesusJ,KrymskayaM,ToweM,PoretskyL.Diabetesself-managementeducationforthe
deaf population. 70th Scientific Sessions of the American Diabetes Association, Abstract 1039-P,Orlando,FL,June25-29,2010.
82. AlfonsoB,MedvedovskyB,RapoportD,ArakiT,DubrowA,PoretskyL. Useof hemodialysis in apatient with hyperosmolar hyperglycemic state and rhabdomyolysis – case report and literaturereview.93rdAnnualMeetingoftheEndocrineSociety.AbstractPI-560,Boston,MA,June4-7,2011.
83. Suwandhi P, Pareek A, Sy V, Seth A, Kim SY, Branis N, Seto-Young D, Poretsky L. Effect of
Thiazolidinediones on Osteoblast Biomarkers. 93rd Annual Meeting of the Endocrine Society.AbstractPI-189,Boston,MA,June4-7,2011.
84. DeJesus J, Krymskaya M, Poretsky L. Diabetes Prevention and Management in Hispanic/Latino
Population:TheFriedmanDiabetesInstitute(FDI)Model.AnnualMeetingoftheAmericanDiabetesAssociation,Abstract2153-PO,SanDiego,CA,June24-28,2011.
85. KimSY,SyV,ArakiT,HuangD,KhuranaA,TanD,LiaoE,LiuG,WanS,PoretskyL,Seto-YoungD.
The role of adiponectin in the pathogenesis of gestational diabetes (GDM) in Chinese Americans.ShanghaiInternationalMedicalDevelopmentForumonFamilyMedicine2012,Shanghai,China,May10-11,2012.
86. SyV,KimSY,ArakiT,HuangD,KhuranaA,TanD,LiaoE,LiuG,WanS,PoretskyL,Seto-YoungD.
Decreased total andhighmolecularweight adiponectin are associatedwith gestationaldiabetes inChineseAmericans. 72ndAnnualMeetingof theAmericanDiabetesAssociation,Abstract2539-PO,Philadelphia,PA,June8-12,2012.
87. SyV,KimSY,ArakiT,HuangD,KhuranaA,TanD,LiaoE,LiuG,WanS,PoretskyL,Seto- YoungD.
Totaladiponectin,butnotTNF-α,IL-6orMCP-1,correlateswiththeincreasingglucoseintoleranceinpregnantChinese-Americanwomen. 94thAnnualMeetingof theEndocrineSociety. AbstractSUN-213,Houston,TX,June23-26,2012.
88. Spritzler J, Stein DS, Bilello J, Poretsky L, Pakes G, Mildvan D. Tumor necrosis factor-α soluble
receptor type II level is an independent predictor of HIV disease progression after 8 weeks in aclinical endpoint trial (ACTG 320) in advanced HIV infection. XIX International AIDS Conference,AbstractA-452-0015-03979,Washington,DC,July22-27,2012.
LEONIDPORETSKY,M.D.
30
89. Kim SY, Sy V, Babushkin N, Tan D, Liao EP, Liu G, Wan S, Poretsky L, Seto-Young D. Unlike inCaucasians,FGF-21andRBP4donotdifferinChinese-Americanwomenwithorwithoutgestationaldiabetes.95thAnnualMeetingoftheEndocrineSociety,AbstractSAT-809,SanFrancisco,CA,June15-18,2013.
90. HirthY,BabushkinN,SyV,SethAK,PareekAS,LinYK,PoretskyL,Seto-YoungD.
ThiazolidinedioneeffectsonthemineralcontentandthecomponentsoftheWntsignalingpathwayin the human osteoblasts. 95th Annual Meeting of the Endocrine Society, Abstract SUN-214, SanFrancisco,CA,June15-18,2013.
91. StrikerGE,Yubero-SerranoEM,SwamyS,ElliotSJ,CaiW,ChenX,McKeeE,,KalajA,KruckelmanF,Tirri L, Mantha K, Rayfield EJ, Uribarri J, Harbord N, Tamler R, Parikh G, Busta A, Poretsky L,Woodward M, Vlassara H. Reversal of suppressed estrogen receptor α and anti-oxidant levels:Possible benefits for cardiovascular disease (CVD) in diabetic kidney disease (DKD). 95th AnnualMeetingoftheEndocrineSociety,Abstract80-LB,SanFrancisco,CA,June15-18,2013.
92. BustaA,PoretskyL,Yubero-SerranoE,WoodwardM,VlassaraH,StrikerGE.TheeffectofSevelamer
on oxidant stress and albuminuria in patients with type 2 diabetes and kidney disease: Arandomized, controlled study. 7th Annual Friedman Fellows Symposium at the 74th ScientificSessionsoftheAmericanDiabetesAssociation,SanFrancisco,CA,June13-17,2014.
93. OngEC,PatelR,PoretskyL.Anatypicalpresentationofpituitarysarcoidosis:Acasereport.16thInternational Congress of Endocrinology andTheEndocrine Society 96thAnnualMeeting, AbstractSAT-0707,Chicago,IL,June21-24,2014.
94. Striker GE, Yuberro-Serrano E, Poretsky L, Vlassara H. Control of oral advanced glycation
endproducts(AGEs)bysevelamercarbonateimprovesglucosemetabolismandalbuminuriainStage2-4diabetickidneydisease(DKD).16thInternationalCongressofEndocrinologyandTheEndocrineSociety96thAnnualMeeting,AbstractSAT-0988,Chicago,IL,June21-24,2014.
95. IslamJR,Seto-YoungDLT,LesserM,RosenwaksZ,PoretskyL. Doesirisinhaveaneffectonfemalereproductivefunction?Initialin-vitrostudies.16thInternationalCongressofEndocrinologyandTheEndocrineSociety96thAnnualMeeting,AbstractMON-0053,Chicago,IL,June21-24,2014.
96. Kambo V, Wakim W, Poretsky L. Readmission rates for patients with secondary diagnosis of
diabetes are increased regardles of primary diagnosis. Endocrine Society 97th Annual Meeting,AbstractTHR-184,SanDiego,CA,March5-8,2015.
97. Kambo, V., Lutsky, L., Poretsky L. Extremely short (1day) length of stay (LOS) in patients withdiabetes(DM)isassociatedwithhighreadmissionrates(RR).75thAnnualMeetingoftheAmericanDiabetesAssociation,Abstract1370-P,Boston,MA,June5-9,2015.
98. AvtanskiDB,HirthY,BabushkinN,SyV,SharmaD,PoretskyL,Seto-YoungDL. InVitroeffectsofpioglitazone on the expression of Wnt signaling pathway components and markers of bonemineralization.EndocrineSociety98thAnnualMeeting,Abstract,Boston,MA,April1-4,2016.
LEONIDPORETSKY,M.D.
31
99. AvtanskiD,KuppusamyP,SonmezH,ShnayderV,WolfeA,PavlovVA,TraceyKJ,PoretskyL.Plasmalevelsofresistincorrelatewithadenylylcyclase-associatedprotein1(CAP1)indiet-inducedobesitymousemodel. EndocrineSociety99thAnnualMeeting,Abstract#SAT-573,Orlando,FL,April1-4,2017.
100. Sonmez H, Kambo V, Lutsky L,Poretsky L. The readmission rates in patients with and without
diabetes mellitus at an urban teaching hospital. 77th Annual Meeting of the American DiabetesAssociation,Abstract1352-P,SanDiego,CA,June9-13,2017.
101. AvtanskiD,GarciaA,CaraballoB,ThangeswaranP,Bianco J,LaviA,MarinS,RoncaC,PoretskyL.
Resistin increases breast cancer cell motility and induces cellular mesenchymal reprograming.EndocrineSociety100thAnnualMeeting,Abstract#SAT-329,Chicago,IL,March17-20,2018.
102. AvtanskiD,GarciaA,ThangeswaranP, CaraballoB, LaviA,Bianco J,Marin S,RoncaC,PoretskyL.Resistininhibitsinsulinsignalinginadenylylcyclase-associatedprotein1(CAP1)-dependentmanner.EndocrineSociety100thAnnualMeeting,Abstract#SUN-141,Chicago,IL,March17-20,2018.
103. Avtanski D, Garcia A, Thangeswaran P, Caraballo-Bordon B,Poretsky L. Role of adenylyl cyclase-associatedprotein1(CAP1)inmediatingresistinactionsinmouselivercells.78thAnnualMeetingoftheAmericanDiabetesAssociation,Abstract1754-P,Orlando,FL,June22-26,2018.
104.ChenK,WeberD,SatlofL,LaviA,BahlK,KaiserM,PoretskyL,AvtanskiD.Resistininducesepithelial
to mesenchymal transition (EMT) in breast cancer cells through activation of AXL tyrosine kinasereceptor.EndocrineSociety101thAnnualMeeting,Abstract#5553,NewOrleans,LA,March22-26,2019.
105. Avtanski D, Lavi A, Bahl K, Kaiser M, Weber D, Satlof L, Chen K, Poretsky L. Proinflammatory
cytokines modulate resistin expression in breast cancer cells. Endocrine Society 101th AnnualMeeting,Abstract#5562,NewOrleans,LA,March22-26,2019.
106. Sajan A, Paliou M, Colon D, Ziskovich K, Poretsky L. Improving transgender care through
comprehensive wellness program in the Endocrine Division: Early experience. Endocrine Society101thAnnualMeeting,Abstract#5781,NewOrleans,LA,March22-26,2019.
107. BasmanC,AvtanskiD,ZiskovichK,JonasR,FishmanS,SonmezH,RashidU,KodraA,StoffelsG,Lesser
M,SinghV,PoretskyL.Serumlevelsoftheadvancedglycationendproduct(AGE)pentosidinedonotcorrelatewiththeextentofcoronaryarterydiseaseassessedbySYNTAXscore.79thAnnualMeetingoftheAmericanDiabetesAssociation,Abstract2215-PUB,SanFrancisco,CA,June7-11,2019.
U.S.PATENTS:1. PoretskyL.U.S.Patent#4,861,073Newspaperholder,1989.
2. PoretskyL, Seto-YoungD. Use of thiazolidinediones for partial inhibition of androgen binding to
aromatase.U.S.PatientApplicationNo.12/463,522.Patentpending,2009.
LEONIDPORETSKY,M.D.
32
OTHER:1. SilverR,PoretskyL, Flier JS. TreatmentofNecrobiosis LipoidicaDiabeticorum. JAmerMedAssoc
254:3,422-423,1985(Letter).2. Acknowledgment:Experimentalworkpublished inGrigorescuF, Flier JS,KahnCR. Defect in insulin
receptorphosphorylationinerythrocytesandfibroblastsassociatedwithsevereinsulinresistance. J.BiolChem259:15003-15006,1984.
3. Novic D,Poretsky L, KalinM. Thyroid-function tests in patients treatedwithmethadone. Clinical
Chemistry35:1807-1808,1989(Letter).4. PoretskyL.Specificity-spilloverphenomenoninthehumanovary.NEnglJMed,321:7,p.474,1989
(Letter).5. Acknowledgment:Helpfulcommentspublished inSingerF,TalaveraW,ZumoffB. Elevated levelsof
anotensin-coveringenzymeinpneumocystiscariniipneumonia.Chest95;803-806,1989.6. PoretskyL.Medicaidproposal.TheNewYorkTimes,July20,1990;pA26(Letter).7. PoretskyL.OvarianInsulin-likeGrowthFactors.AnnInternMed.117-:535,1992(Letter).
8. PoretskyL.ChoicesforPatients(letter),TheNewYorkTimes,November30,1993.9. PoretskyL.DiagnosticScale(letter).TheNewYorkTimes,June18,1994.10. Rodriguez G.Poretsky L. Toradol Instead of Tapazole (letter). American Journal ofHealth System
Pharmacy,Vol52:1098,1995.11. StolarczykR,LauferI,PoretskyL.ReplytoEriksson.DiabCare20:1045,1997(letter).12. PoretskyL.Purchase(shortstory).NovoyeRusskoeSlovo(NewRussianWord,RussianDaily Newspaper):p62,November,7,1997.13. PoretskyL.“ChanukahinNewYork”MetropolitanDiary,TheNewYorkTimes,January26,1998.14. PoretskyL.Interviewedfor“Populardrugfordiabetesisscrutinized”byDavidMorrow,The NewYorkTimes,March26,1999.15. PoretskyL.Chichikov’sList(letter)TheNewYorkTimes,April9,1999.16. PoretskyL.“Greatblueheron”(apoem).OutdoorMagazine,Fall2000,p.13.17. PoretskyL.“Thebearstanza”(apoem).TheRiverReporter,Jan4th-10thissue,2001.18. PoretskyL.“Runningdeer”(apoem).TheRiverReporter,May24,2001.19. PoretskyL.Interviewedfor“Bristol-Meyersfightstolockinpatients”byGardinerHarris,WallStreet
Journal,May21,2001.20. PoretskyL.“Businessisbusiness”,MetropolitanDiary,TheNewYorkTimes,October8,2001.
LEONIDPORETSKY,M.D.
33
21. PoretskyL.“Hareinthepark”(apoem).OutdoorsMagazine,p.75,October,2001.
22. Poretsky L. Interviewed for “Abbot pushes its Synthroid, but should it?” by Gardiner Harris,Wall
StreetJournal,July17,2002.
23. PoretskyL.“Anoutdooradventure”(apoem).RiverReporter,August15-21,2002.
24. PoretskyL.“Tofallinlove”(apoem).RiverReporter,February13-19,2003.25. PoretskyL.Interviewedfor“Inthetreatmentofdiabetessuccessoftendoesnotpay”.TheNewYork
Times,January11,2006.
26. PoretskyL.Interviewedfor“$6milliongiftresurrectsabootcampfordiabetics”.TheNew YorkTimes,April2,2006.27. PoretskyL.Interviewedfor“Whatyourdoctorisn’tsaying”.Men’sHealth,p.177,November 2006.28. PoretskyL.“Bonus”,MetropolitanDiary,TheNewYorkTimes,December25,2006.29. PoretskyL.“Mother’shand”(apoem).JewishCurrents,May-June2007.30. PoretskyL.Interviewedfor“Victoriesoverdiabetes”.DailyNews,October28,2007.31. PoretskyL.Interviewedfor“BethIsraelMedicalCenterInauguratesTheGeraldJ.Friedman DiabetesInstitute.”MedicalUpdate8:4,December2007.32. PoretskyL.“IceCreamandTolstoy,”MetropolitanDiary,TheNewYorkTimes,December3, 2007.33. PoretskyL.Interviewedfor“Bedeviledbythesugarsickness,”TheNewYorkTimes,March2,2008.34. PoretskyL.Interviewedfor“Regulatorsscuttledrugfordiabetes,“TheWallStreetJournal, September24,2010.37. PoretskyL.“Choiceswemake,”MetropolitanDiary,TheNewYorkTimes,June27,2011.
37. PoretskyL.Re:“Betteruseofmedicalrecordsisgoodasfarasitgoes,”LettertotheEditor,TheWall
StreetJournal,September26,2011.38. Poretsky L. Re: “At what age would it be appropriate to perform genetic testing for diabetes?”
Point/Counter,EndocrineToday,p.11,September2011.39. PoretskyL.Galleryexhibit:“Bemine…always”,anexhibitionoflovepoemsandphotos.Poem:“Your
Lips” by Leonid Poretsky and an art object by Leonid Poretsky and Lee Clayton. Alliance Gallery,Narrowsburg,NewYork,January28-February18,2012.
LEONIDPORETSKY,M.D.
34
40. PoretskyL. Re:“Meetthemarriagekiller,”LettertotheEditor,TheWallStreet Journal,February8,2012.
41. PoretskyL.TheAGE-LessWay(onlinebookreview),Amazon.com,July23,2012.42. Poretsky L. The Jewish plot: A story. On line: http://jewishcurrents.org/the-jewish-plot-a-story-
16445,April15,2013.Inprint:“JewishCurrents”,pp40-42,Summer2013.43. Poretsky L. Re: “Physician, hear thyself—Why communicationmatters,” Letters to the Editor, The
WallStreetJournal,April20-21,2013.44. Poretsky L. Re: “Readmissions often aren’t culpable acts.” Letters to the Editor, TheWall Street
Journal,May20,2013.45. PoretskyL. Re: “TraditionalMedicareshouldbeallowedtocompete.” EducationUpdate,Vol.XXII,
No.3,pp14,January/February2017.46. PoretskyL.ConceptualArtEvent:“Thankyouforcoming.”DaciaGallery,NewYork,May20,2017.47. PoretskyL.LHHAuxiliaryPhotoContest:“GoodMorningNewYork.”Honorablemention,November
12,2019,NewYork.
VOLUNTEERING:January17-24,2015VolunteerPhysicianfortheUnitedStatesBobsledandSkeletonFederationEurope
CupSkeletonTeam.-SaintMoritz,Switzerland-Innsbruck,Austria
LEONIDPORETSKY,M.D.
35
TRAINEES
Name
LevelofTrainee
RoleinTrainingandInclusive
DatesofTraining
TrainingVenue
Trainees’CurrentStatus/Employment
MarshaTolentino,MD
EndocrineFellow
07/01/99–06/30/01
MentorforClinicalResearch
PrivatePractice,Cebu,Philippines
AnilShrestha,MD
EndocrineFellow
07/01/99–06/30/01
MentorforClinicalResearch
Endocrinologist,BaptistMedicalCenter,FL
SusanZweig,MD
EndocrineFellow
07/01/00–06/30/02
MentorforClinicalResearch
Endocrinologist,NewYorkUniversity
JacekZajac,MD
EndocrineFellow
07/01/00–06/30/02
MentorforClinicalResearch
EndocrinologistElmhurstHospital,IL
AndreaFerenczi,MD
EndocrineFellow
07/01/01-06/30/03
MentorforClinicalResearch
Endocrinologist,BannerBoswellMedicalCenter,AZ
MarziehSalehi,MD
EndocrineFellow
07/01/01-06/30/03
MentorforClinicalResearch
Endocrinologist,CedarsSinaiMedicalCenter,TX
AidaSaliby,MD
ECRIPFellow/Endocrinologist
07/01/0206/30/15
MentorforClinicalResearch
Chief,EndocrineNYPHDowntown,NY
RafaelBravo-Vera,MD
EndocrineFellow
07/01/02-06/30/04
MentorforClinicalResearch
EndocrinologistNovartis,MexicoCity
ArsalanSheikh,DO
EndocrineFellow
07/01/02-06/30/04
MentorforClinicalResearch
Endocrinologist,UniversityofMarylandMedicalCenter
MariaPaliou,MD
EndocrineFellow
07/01/03-06/30/05
MentorforClinicalResearch
Chief,Endocrine,HarlemHospital,NY
JonathanSchlosser,DO
EndocrineFellow
07/01/03-06/30/05
MentorforClinicalResearch
Endocrinologist,NyackHospital
JuliaKaplun,MD
EndocrineFellow
07/01/04-06/30/06
MentorforClinicalResearch
Endocrinologist,NyackHospital
LisenLiu,MD
EndocrineFellow
07/01/04-06/30/06
MentorforClinicalResearch
PrivatePractice,NewYorkCity
PariniPatel,MD
ECRIPFellow/EndocrineFellow
07/01/04-06/30/08
MentorforClinicalResearch
Endocrinologist,HackensackMeridian,NJ
DimitarAvtanski,Ph.D.
Fellow-ThankstoScandinavia
2004-2008
MentorforClinicalResearch
Director,FriedmanEndocrineLaboratoryLHH
MarinaStrizhevsky,DO
ECRIPFellow/EndocrineFellow
07/01/05-06/30/09
MentorforClinicalResearch
EndocrinologistJerseyCityMedicalCenter
DimaYeshou,MD
IMResident
2005
MentorforClinicalResearch
Endocrinologist,HackensackUniversity,NJ
RamonE.Martinez,MD
EndocrineFellow
07/01/05-06/30/07
MentorforClinicalResearch
Endocrinologist,MountSinaiMedicalCenter,FL
LiqunSong,MD
EndocrineFellow
07/01/05-06/30/07
MentorforClinicalResearch
Endocrinologist,GriffinHospital,CT
YuriyGurevich,DO
EndocrineFellow
07/01/06-06/30/08
MentorforClinicalResearch
Endocrinologist,NyackHospital
MichaelGoldman,MD
ECRIPFellow
2007
MentorforClinicalResearch
Nephrologist–JamaicaHospital,Queens,NY
LEONIDPORETSKY,M.D.
36
Name
LevelofTrainee
RoleinTrainingandInclusive
DatesofTraining
TrainingVenue
Trainees’CurrentStatus/Employment
ZinovyAbelev,MD
EndocrineFellow
07/01/07–06/30/09
MentorforClinicalResearch
Endocrinologist,NorthwellHealth
StefanCadag,DO
EndocrineFellow
07/01/08-06/30/10
MentorforClinicalResearch
Endocrinologist,MountSinaiBethIsrael
SagitZolotov,MD
EndocrineFellowResearchTrack
07/01/0506/30/10
MentorforClinicalResearch
PrivatePractice,Israel
GrishmaParikh,MD
ECRIPFellowFriedmanFellowEndocrineFellow
07/01/07–06/30/10
MentorforClinicalResearch
Endocrinologist,AssistantProfessor,IcahnSchoolofMedicine
BiancaAlfonso,MD
ECRIPFellowEndocrineFellow
01/01/07-06/30/11
MentorforClinicalResearch
Endocrinologist,SouthMiamiHospital
TakakoAraki,MD
FriedmanFellowEndocrineFellow
07/01/08-06/30/11
MentorforClinicalResearch
Endocrinologist,UniversityofMinnesota
YunFeng,MD
EndocrineFellow
07/01/10-06/30/12
MentorforClinicalResearch
Endocrinologist,MountSinaiBethIsrael
AmitSeth,MD
ECRIPFellow/EndocrineFellow
07/01/09-06/30/12
MentorforClinicalResearch
Endocrinologist,NewarkBethIsraelMedicalCenter
GordonBurke,MD
MedicalStudent
2009
MentorforClinicalResearch
Internist,BostonUniversityFamilyGroup
PrajeshM.Joshi,MD
IMResident
2009
MentorforClinicalResearch
Endocrinologist,MercyHospital,Arkansas
MiroslavaVaradinova,PhD
ResearchFellow
2009
MentorforClinicalResearch
Sofia,Bulgaria
DavidGajzer,MD
FriedmanFellowResearchFellow
2010
MentorforClinicalResearch
Fellow–Anesthesiology,Miami,FL
SumeiKato,MD
IMResident
2010
MentorforClinicalResearch
OncologistUCSanDiego
PaulineSuwandhi,MD
FriedmanFellow
2010
MentorforClinicalResearch
Geriatrics,MontefioreHospital
DinaRapoport,MD
IMResident
2011
MentorforClinicalResearch
Endocrinologist,NYUHospital
So-YoungKim,MD
IMResident
2011
MentorforClinicalResearch
Endocrinologist,WeillCornellMedicine
NataliaBranis,MD
IMResident
2011
MentorforClinicalResearch
EndocrinologistMountSinaiBethIsrael
NicoleBabushkin
ResearchAssistant
2012
MentorforClinicalResearch
Internist,OceanMedicalCenter,NJ
VanessaSy-Po,MD
Volunteer
2012
MentorforClinicalResearch
FMLA–BirthofChild
JulieIslam,MBBS
ResearchFellow/FriedmanFellow
07/01/12–06/30/14
MentorforClinicalResearch
EndocrineFellow,Scripps,LaJolla,CA
LEONIDPORETSKY,M.D.
37
Name
LevelofTrainee
RoleinTrainingandInclusive
DatesofTraining
TrainingVenue
Trainees’CurrentStatus/Employment
CarlaRomero,MD
EndocrineFellow
07/01/11-06/30/13
MentorforClinicalResearch
Endocrinologist,NorthShoreLIJ-Northwell
RonakPatel,MD
EndocrineFellow
07/01/12-06/30/14
MentorforClinicalResearch
Endocrinologist,MorristownMedicalCenter,NJ
ZiJianChen,MD
EndocrineFellow
07/01/12-06/30/14
MentorforClinicalResearch
Endocrinologist,MountSinaiMedicalCenter
ErwynOng,MD
EndocrineFellow
07/01/13-09/01/14
MentorforClinicalResearch
Endocrinologist,PresbyterianMedicalGroup,NewMexico
HalisSonmez,MD
EndocrineFellow/ECRIPFellow
07/01/13-09/01/14;12/01/15–04/04/17
MentorforClinicalResearch
Endocrinologist,NYUQueensHospital,NY
MahmoudHassan,MD
ResearchFellow
01/01/14–09/01/14
MentorforClinicalResearch
Master’sProgram,JohnHopkinsUniversity,Baltimore,Maryland
SarahFishman,MD
EndocrineFellow
07/01/16–06/30/18
MentorforClinicalResearch
AttendingEndocrinologistLenoxHillHospital
TrishaNewaz,DO
EndocrineFellow
09/27/17–Present
MentorforClinicalResearch
EndocrineFellowLenoxHillHospital
ArpitaBhalodkar,MD
ECRIPFellow/EndocrineFellow
08/01/17-06/30/18;07/01/18-Present
MentorforClinicalResearch
EndocrineFellowLenoxHillHospital
MikailKoroma,MD
ECRIPFellow
02/01/18–07/31/18
MentorforClinicalResearch
OrthopedicResidencyLenoxHillHospital
KarinChen,MD
ECRIPFellow
09/04/18–Present
MentorforClinicalResearch
JuniorAttendingPhysicianDivisionofEndocrinology–LenoxHillHospital
AlenSajan,MD
IMResident
11/2018toPresent
MentorforClinicalResearch
InternalMedicineSpecialistLenoxHillHospital
LEONIDPORETSKY,M.D.
38